1368488
2020
1
heidelberg-university-faculty-of-medicine
50
creator
asc
year
1
187
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22AYDHEMCY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Avanzi%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAvanzi%2C%20C.%2C%20L%26%23xE9%3Bcorch%26%23xE9%3B%2C%20E.%2C%20Rakotomalala%2C%20F.%20A.%2C%20Benjak%2C%20A.%2C%20Rapelanoro%20Rabenja%2C%20F.%2C%20Ramarozatovo%2C%20L.%20S.%2C%20Cauchoix%2C%20B.%2C%20Rakoto-Andrianarivelo%2C%20M.%2C%20Ti%26%23xF3%3B-Coma%2C%20M.%2C%20Leal-Calvo%2C%20T.%2C%20Busso%2C%20P.%2C%20Boy-R%26%23xF6%3Bttger%2C%20S.%2C%20Chauffour%2C%20A.%2C%20Rasamoelina%2C%20T.%2C%20Andrianarison%2C%20A.%2C%20Sendrasoa%2C%20F.%2C%20Spencer%2C%20J.%20S.%2C%20Singh%2C%20P.%2C%20Dashatwar%2C%20D.%20R.%2C%20Narang%2C%20R.%2C%20Berland%2C%20J.-L.%2C%20Jarlier%2C%20V.%2C%20Salgado%2C%20C.%20G.%2C%20Moraes%2C%20M.%20O.%2C%20Geluk%2C%20A.%2C%20Randrianantoandro%2C%20A.%2C%20Cambau%2C%20E.%20and%20Cole%2C%20S.%20T.%20%282020%29.%20%3Cb%3EPopulation%20Genomics%20of%20Mycobacterium%20leprae%20Reveals%20a%20New%20Genotype%20in%20Madagascar%20and%20the%20Comoros%3C%5C%2Fb%3E.%20Frontiers%20in%20Microbiology%20%3Ci%3E11%3C%5C%2Fi%3E%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmicb.2020.00711%27%3Ehttps%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmicb.2020.00711%3C%5C%2Fa%3E%20%5BAccessed%20March%202022%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Population%20Genomics%20of%20Mycobacterium%20leprae%20Reveals%20a%20New%20Genotype%20in%20Madagascar%20and%20the%20Comoros%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Avanzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22L%5Cu00e9corch%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fetra%20Angelot%22%2C%22lastName%22%3A%22Rakotomalala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrej%22%2C%22lastName%22%3A%22Benjak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fahafahantsoa%22%2C%22lastName%22%3A%22Rapelanoro%20Rabenja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lala%20S.%22%2C%22lastName%22%3A%22Ramarozatovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bertrand%22%2C%22lastName%22%3A%22Cauchoix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mala%22%2C%22lastName%22%3A%22Rakoto-Andrianarivelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Ti%5Cu00f3-Coma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thyago%22%2C%22lastName%22%3A%22Leal-Calvo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Busso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefanie%22%2C%22lastName%22%3A%22Boy-R%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tahinamandrato%22%2C%22lastName%22%3A%22Rasamoelina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aina%22%2C%22lastName%22%3A%22Andrianarison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fandresena%22%2C%22lastName%22%3A%22Sendrasoa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20S.%22%2C%22lastName%22%3A%22Spencer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pushpendra%22%2C%22lastName%22%3A%22Singh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Digambar%20Ramchandra%22%2C%22lastName%22%3A%22Dashatwar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rahul%22%2C%22lastName%22%3A%22Narang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Luc%22%2C%22lastName%22%3A%22Berland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudio%20G.%22%2C%22lastName%22%3A%22Salgado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Milton%20O.%22%2C%22lastName%22%3A%22Moraes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annemieke%22%2C%22lastName%22%3A%22Geluk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andriamira%22%2C%22lastName%22%3A%22Randrianantoandro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stewart%20T.%22%2C%22lastName%22%3A%22Cole%22%7D%5D%2C%22abstractNote%22%3A%22Human%20settlement%20of%20Madagascar%20traces%20back%20to%20the%20beginning%20of%20the%20first%20millennium%20with%20the%20arrival%20of%20Austronesians%20from%20Southeast%20Asia%2C%20followed%20by%20migrations%20from%20Africa%20and%20the%20Middle%20East.%20Remains%20of%20these%20different%20cultural%2C%20genetic%2C%20and%20linguistic%20legacies%20are%20still%20present%20in%20Madagascar%20and%20other%20islands%20of%20the%20Indian%20Ocean.%20The%20close%20relationship%20between%20human%20migration%20and%20the%20introduction%20and%20spread%20of%20infectious%20diseases%2C%20a%20well-documented%20phenomenon%2C%20is%20particularly%20evident%20for%20the%20causative%20agent%20of%20leprosy%2C%20Mycobacterium%20leprae.%20In%20this%20study%2C%20we%20used%20whole-genome%20sequencing%20%28WGS%29%20and%20molecular%20dating%20to%20characterize%20the%20genetic%20background%20and%20retrace%20the%20origin%20of%20the%20M.%20leprae%20strains%20circulating%20in%20Madagascar%20%28n%20%3D%2030%29%20and%20the%20Comoros%20%28n%20%3D%203%29%2C%20two%20islands%20where%20leprosy%20is%20still%20considered%20a%20public%20health%20problem%20and%20monitored%20as%20part%20of%20a%20drug%20resistance%20surveillance%20program.%20Most%20M.%20leprae%20strains%20%2897%25%29%20from%20Madagascar%20and%20Comoros%20belonged%20to%20a%20new%20genotype%20as%20part%20of%20branch%201%2C%20closely%20related%20to%20single%20nucleotide%20polymorphism%20%28SNP%29%20type%201D%2C%20named%201D-Malagasy.%20Other%20strains%20belonged%20to%20the%20genotype%201A%20%283%25%29.%20We%20sequenced%2039%20strains%20from%20nine%20other%20countries%2C%20which%2C%20together%20with%20previously%20published%20genomes%2C%20amounted%20to%20242%20genomes%20that%20were%20used%20for%20molecular%20dating.%20Specific%20SNP%20markers%20for%20the%20new%201D-Malagasy%20genotype%20were%20used%20to%20screen%20samples%20from%2011%20countries%20and%20revealed%20this%20genotype%20to%20be%20restricted%20to%20Madagascar%2C%20with%20the%20sole%20exception%20being%20a%20strain%20from%20Malawi.%20The%20overall%20analysis%20thus%20ruled%20out%20a%20possible%20introduction%20of%20leprosy%20by%20the%20Austronesian%20settlers%20and%20suggests%20a%20later%20origin%20from%20East%20Africa%2C%20the%20Middle%20East%2C%20or%20South%20Asia.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221664-302X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmicb.2020.00711%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A54%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22UXDPPEQL%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22BRUUT%21%22%2C%22parsedDate%22%3A%222020-03-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBRUUT%21%20%282020%29.%20Loulou.%206%20March%202020%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.youtube.com%5C%2Fwatch%3Fv%3DjPwFWmY271A%27%3Ehttps%3A%5C%2F%5C%2Fwww.youtube.com%5C%2Fwatch%3Fv%3DjPwFWmY271A%3C%5C%2Fa%3E%20%5BAccessed%20October%202022%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22videoRecording%22%2C%22title%22%3A%22Loulou%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22director%22%2C%22name%22%3A%22BRUUT%21%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22videoRecordingFormat%22%3A%22%22%2C%22studio%22%3A%22%22%2C%22date%22%3A%222020-03-06%22%2C%22runningTime%22%3A%225%3A11%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.youtube.com%5C%2Fwatch%3Fv%3DjPwFWmY271A%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-10-12T13%3A27%3A30Z%22%7D%7D%2C%7B%22key%22%3A%229WXYS4PP%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%20and%20Poljak%22%2C%22parsedDate%22%3A%222020-04-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECambau%2C%20E.%20and%20Poljak%2C%20M.%20%282020%29.%20%3Cb%3ESniffing%20animals%20as%20a%20diagnostic%20tool%20in%20infectious%20diseases%3C%5C%2Fb%3E.%20Clinical%20Microbiology%20and%20Infection%20%3Ci%3E26%3C%5C%2Fi%3E%2C%20431%26%23x2013%3B435%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2019.10.036%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2019.10.036%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Sniffing%20animals%20as%20a%20diagnostic%20tool%20in%20infectious%20diseases%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Poljak%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-04-01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2019.10.036%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2819%2930591-9%5C%2Ffulltext%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A56%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22SBB4JW6V%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chauffour%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EChauffour%2C%20A.%2C%20Robert%2C%20J.%2C%20Veziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Pethe%2C%20K.%20and%20Jarlier%2C%20V.%20%282020%29.%20%3Cb%3ETelacebec%20%28Q203%29-containing%20intermittent%20oral%20regimens%20sterilized%20mice%20infected%20with%20Mycobacterium%20ulcerans%20after%20only%2016%20doses%3C%5C%2Fb%3E.%20PLOS%20Neglected%20Tropical%20Diseases%20%3Ci%3E14%3C%5C%2Fi%3E%2C%20e0007857%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0007857%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pntd.0007857%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Telacebec%20%28Q203%29-containing%20intermittent%20oral%20regimens%20sterilized%20mice%20infected%20with%20Mycobacterium%20ulcerans%20after%20only%2016%20doses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Pethe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%5D%2C%22abstractNote%22%3A%22Buruli%20ulcer%20%28BU%29%2C%20caused%20by%20Mycobacterium%20ulcerans%2C%20is%20currently%20treated%20with%20a%20daily%20combination%20of%20rifampin%20and%20either%20injectable%20streptomycin%20or%20oral%20clarithromycin.%20An%20intermittent%20oral%20regimen%20would%20facilitate%20treatment%20supervision.%20We%20first%20evaluated%20the%20bactericidal%20activity%20of%20newer%20antimicrobials%20against%20M.%20ulcerans%20using%20a%20BU%20animal%20model.%20The%20imidazopyridine%20amine%20telacebec%20%28Q203%29%20exhibited%20high%20bactericidal%20activity%20whereas%20tedizolid%20%28an%20oxazolidinone%20closely%20related%20to%20linezolid%29%2C%20selamectin%20and%20ivermectin%20%28two%20avermectine%20compounds%29%20and%20the%20benzothiazinone%20PBTZ169%20were%20not%20active.%20Consequently%2C%20telacebec%20was%20evaluated%20for%20its%20bactericidal%20and%20sterilizing%20activities%20in%20combined%20intermittent%20regimens.%20Telacebec%20given%20twice%20a%20week%20in%20combination%20with%20a%20long-half-life%20compound%2C%20either%20rifapentine%20or%20bedaquiline%2C%20sterilized%20mouse%20footpads%20in%208%20weeks%2C%20i.e.%20after%20a%20total%20of%20only%2016%20doses%2C%20and%20prevented%20relapse%20during%20a%20period%20of%2020%20weeks%20after%20the%20end%20of%20treatment.%20These%20results%20are%20very%20promising%20for%20future%20intermittent%20oral%20regimens%20which%20would%20greatly%20simplify%20BU%20treatment%20in%20the%20field.%22%2C%22date%22%3A%2231%20ao%5Cu00fbt%202020%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pntd.0007857%22%2C%22ISSN%22%3A%221935-2735%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fjournals.plos.org%5C%2Fplosntds%5C%2Farticle%3Fid%3D10.1371%5C%2Fjournal.pntd.0007857%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A50%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22GQUCM5VQ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cox%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ECox%2C%20V.%2C%20McKenna%2C%20L.%2C%20Acquah%2C%20R.%2C%20Reuter%2C%20A.%2C%20Wasserman%2C%20S.%2C%20Vambe%2C%20D.%2C%20Ustero%2C%20P.%2C%20Udwadia%2C%20Z.%2C%20Trivi%26%23xF1%3Bo-Duran%2C%20L.%2C%20Tommasi%2C%20M.%2C%20Skrahina%2C%20A.%2C%20Seddon%2C%20J.%20A.%2C%20Rodolfo%2C%20R.%2C%20Rich%2C%20M.%2C%20Padanilam%2C%20X.%2C%20Oyewusi%2C%20L.%2C%20Ohler%2C%20L.%2C%20Lungu%2C%20P.%2C%20Loveday%2C%20M.%2C%20Khan%2C%20U.%2C%20Khan%2C%20P.%2C%20Hughes%2C%20J.%2C%20Hewison%2C%20C.%2C%20Guglielmetti%2C%20L.%20and%20Furin%2C%20J.%20%282020%29.%20%3Cb%3EClinical%20perspectives%20on%20treatment%20of%20rifampicin-resistant%5C%2Fmultidrug-resistant%20TB%3C%5C%2Fb%3E.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%3Ci%3E24%3C%5C%2Fi%3E%2C%201134%26%23x2013%3B1144%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.20.0330%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.20.0330%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20perspectives%20on%20treatment%20of%20rifampicin-resistant%5C%2Fmultidrug-resistant%20TB%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22McKenna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Acquah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Reuter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Wasserman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Vambe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Ustero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Trivi%5Cu00f1o-Duran%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Tommasi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Seddon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Rodolfo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Rich%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%22%2C%22lastName%22%3A%22Padanilam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Oyewusi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Ohler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Lungu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Loveday%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Hewison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Furin%22%7D%5D%2C%22abstractNote%22%3A%22Rapid%20diagnostics%2C%20newer%20drugs%2C%20repurposed%20medications%2C%20and%20shorter%20regimens%20have%20radically%20altered%20the%20landscape%20for%20treating%20rifampicin-resistant%20TB%20%28RR-TB%29%20and%20multidrug-resistant%20TB%20%28MDR-TB%29.%20There%20are%20multiple%20ongoing%20clinical%20trials%20aiming%20to%20build%20a%20robust%20evidence%20base%20to%20guide%5CnRR%5C%2FMDR-TB%20treatment%2C%20and%20both%20observational%20studies%20and%20programmatic%20data%20have%20contributed%20to%20advancing%20the%20treatment%20field.%20In%20December%202019%2C%20the%20WHO%20issued%20their%20second%20%5Cu2018Rapid%20Communication%5Cu00b4%20related%20to%20RR-TB%20management.%20This%20reiterated%20their%20prior%20recommendation%20that%20a%20majority%5Cnof%20people%20with%20RR%5C%2FMDR-TB%20receive%20all-oral%20treatment%20regimens%2C%20and%20now%20allow%20for%20specific%20shorter%20duration%20regimens%20to%20be%20used%20programmatically%20as%20well.%20Many%20TB%20programs%20need%20clinical%20advice%20as%20they%20seek%20to%20roll%20out%20such%20regimens%20in%20their%20specific%20setting.%20In%20this%20Perspective%2C%20we%20highlight%5Cnour%20early%20experiences%20and%20lessons%20learned%20from%20working%20with%20National%20TB%20Programs%2C%20adult%20and%20pediatric%20clinicians%20and%20civil%20society%2C%20in%20optimizing%20treatment%20of%20RR%5C%2FMDR-TB%2C%20using%20shorter%2C%20highly-effective%2C%20oral%20regimens%20for%20the%20majority%20of%20people%20with%20RR%5C%2FMDR-TB.%22%2C%22date%22%3A%222020-11-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.20.0330%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A54%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22RDV6XIIK%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Daley%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-14%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EDaley%2C%20C.%20L.%2C%20Iaccarino%2C%20J.%20M.%2C%20Lange%2C%20C.%2C%20Cambau%2C%20E.%2C%20Wallace%2C%20R.%20J.%2C%20Jr%2C%20Andrejak%2C%20C.%2C%20B%26%23xF6%3Bttger%2C%20E.%20C.%2C%20Brozek%2C%20J.%2C%20Griffith%2C%20D.%20E.%2C%20Guglielmetti%2C%20L.%2C%20Huitt%2C%20G.%20A.%2C%20Knight%2C%20S.%20L.%2C%20Leitman%2C%20P.%2C%20Marras%2C%20T.%20K.%2C%20Olivier%2C%20K.%20N.%2C%20Santin%2C%20M.%2C%20Stout%2C%20J.%20E.%2C%20Tortoli%2C%20E.%2C%20van%20Ingen%2C%20J.%2C%20Wagner%2C%20D.%20and%20Winthrop%2C%20K.%20L.%20%282020%29.%20%3Cb%3ETreatment%20of%20Nontuberculous%20Mycobacterial%20Pulmonary%20Disease%3A%20An%20Official%20ATS%5C%2FERS%5C%2FESCMID%5C%2FIDSA%20Clinical%20Practice%20Guideline%3C%5C%2Fb%3E.%20Clinical%20Infectious%20Diseases%20%3Ci%3E71%3C%5C%2Fi%3E%2C%20e1%26%23x2013%3Be36%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciaa241%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciaa241%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20of%20Nontuberculous%20Mycobacterial%20Pulmonary%20Disease%3A%20An%20Official%20ATS%5C%2FERS%5C%2FESCMID%5C%2FIDSA%20Clinical%20Practice%20Guideline%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20L%22%2C%22lastName%22%3A%22Daley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20M%22%2C%22lastName%22%3A%22Iaccarino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J%2C%20Jr%22%2C%22lastName%22%3A%22Wallace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Andrejak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan%22%2C%22lastName%22%3A%22Brozek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E%22%2C%22lastName%22%3A%22Griffith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwen%20A%22%2C%22lastName%22%3A%22Huitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shandra%20L%22%2C%22lastName%22%3A%22Knight%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%22%2C%22lastName%22%3A%22Leitman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodore%20K%22%2C%22lastName%22%3A%22Marras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20N%22%2C%22lastName%22%3A%22Olivier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Santin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20E%22%2C%22lastName%22%3A%22Stout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enrico%22%2C%22lastName%22%3A%22Tortoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakko%22%2C%22lastName%22%3A%22van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Wagner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20L%22%2C%22lastName%22%3A%22Winthrop%22%7D%5D%2C%22abstractNote%22%3A%22Nontuberculous%20mycobacteria%20%28NTM%29%20represent%20over%20190%20species%20and%20subspecies%2C%20some%20of%20which%20can%20produce%20disease%20in%20humans%20of%20all%20ages%20and%20can%20affect%20both%20pulmonary%20and%20extrapulmonary%20sites.%20This%20guideline%20focuses%20on%20pulmonary%20disease%20in%20adults%20%28without%20cystic%20fibrosis%20or%20human%20immunodeficiency%20virus%20infection%29%20caused%20by%20the%20most%20common%20NTM%20pathogens%20such%20as%20Mycobacterium%20avium%20complex%2C%20Mycobacterium%20kansasii%2C%20and%20Mycobacterium%20xenopi%20among%20the%20slowly%20growing%20NTM%20and%20Mycobacterium%20abscessus%20among%20the%20rapidly%20growing%20NTM.%20A%20panel%20of%20experts%20was%20carefully%20selected%20by%20leading%20international%20respiratory%20medicine%20and%20infectious%20diseases%20societies%20%28ATS%2C%20ERS%2C%20ESCMID%2C%20IDSA%29%20and%20included%20specialists%20in%20pulmonary%20medicine%2C%20infectious%20diseases%20and%20clinical%20microbiology%2C%20laboratory%20medicine%2C%20and%20patient%20advocacy.%20Systematic%20reviews%20were%20conducted%20around%20each%20of%2022%20PICO%20%28Population%2C%20Intervention%2C%20Comparator%2C%20Outcome%29%20questions%20and%20the%20recommendations%20were%20formulated%2C%20written%2C%20and%20graded%20using%20the%20GRADE%20%28Grading%20of%20Recommendations%20Assessment%2C%20Development%2C%20and%20Evaluation%29%20approach.%20Thirty-one%20evidence-based%20recommendations%20about%20treatment%20of%20NTM%20pulmonary%20disease%20are%20provided.%20This%20guideline%20is%20intended%20for%20use%20by%20healthcare%20professionals%20who%20care%20for%20patients%20with%20NTM%20pulmonary%20disease%2C%20including%20specialists%20in%20infectious%20diseases%20and%20pulmonary%20diseases.%22%2C%22date%22%3A%222020-08-14%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciaa241%22%2C%22ISSN%22%3A%221058-4838%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciaa241%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A53%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22JHD8DAI5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuglielmetti%2C%20L.%2C%20Low%2C%20M.%20and%20McKenna%2C%20L.%20%282020%29.%20%3Cb%3EChallenges%20in%20TB%20regimen%20development%3A%20preserving%20evidentiary%20standards%20for%20regulatory%20decisions%20and%20policymaking%3C%5C%2Fb%3E.%20Expert%20Review%20of%20Anti-infective%20Therapy%20%3Ci%3E18%3C%5C%2Fi%3E%2C%20701%26%23x2013%3B704%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14787210.2020.1756776%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14787210.2020.1756776%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Challenges%20in%20TB%20regimen%20development%3A%20preserving%20evidentiary%20standards%20for%20regulatory%20decisions%20and%20policymaking%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcus%22%2C%22lastName%22%3A%22Low%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22McKenna%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-08-02%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1080%5C%2F14787210.2020.1756776%22%2C%22ISSN%22%3A%221478-7210%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1080%5C%2F14787210.2020.1756776%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T21%3A26%3A22Z%22%7D%7D%2C%7B%22key%22%3A%22AC3AHH57%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222020-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuglielmetti%2C%20L.%2C%20Huerga%2C%20H.%2C%20Khan%2C%20U.%20and%20Varaine%2C%20F.%20%282020%29.%20%3Cb%3EWHO%202019%20guidelines%20on%20drug-resistant%20tuberculosis%20treatment%3A%20based%20on%20evidence%20or%20expert%20opinion%3F%3C%5C%2Fb%3E%20Eur%20Respir%20J%20%3Ci%3E55%3C%5C%2Fi%3E%2C%201901935%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01935-2019%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01935-2019%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22WHO%202019%20guidelines%20on%20drug-resistant%20tuberculosis%20treatment%3A%20based%20on%20evidence%20or%20expert%20opinion%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%22%2C%22lastName%22%3A%22Huerga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Uzma%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-03%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.01935-2019%22%2C%22ISSN%22%3A%221399-3003%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A59%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22WI57GV49%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222020-06%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EGuglielmetti%2C%20L.%2C%20Chiesi%2C%20S.%2C%20Eimer%2C%20J.%2C%20Dominguez%2C%20J.%2C%20Masini%2C%20T.%2C%20Varaine%2C%20F.%2C%20Veziris%2C%20N.%2C%20Ader%2C%20F.%20and%20Robert%2C%20J.%20%282020%29.%20%3Cb%3EBedaquiline%20and%20delamanid%20for%20drug-resistant%20tuberculosis%3A%20a%20clinician%26%23x2019%3Bs%20perspective%3C%5C%2Fb%3E.%20Future%20Microbiology%20%3Ci%3E15%3C%5C%2Fi%3E%2C%20779%26%23x2013%3B799%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2217%5C%2Ffmb-2019-0309%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2217%5C%2Ffmb-2019-0309%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%20and%20delamanid%20for%20drug-resistant%20tuberculosis%3A%20a%20clinician%5Cu2019s%20perspective%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheila%22%2C%22lastName%22%3A%22Chiesi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johannes%22%2C%22lastName%22%3A%22Eimer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Dominguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiziana%22%2C%22lastName%22%3A%22Masini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Ader%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%5D%2C%22abstractNote%22%3A%22Drug-resistant%20tuberculosis%20%28TB%29%20represents%20a%20substantial%20threat%20to%20the%20global%20efforts%20to%20control%20this%20disease.%20After%20decades%20of%20stagnation%2C%20the%20treatment%20of%20drug-resistant%20TB%20is%20undergoing%20major%20changes%3A%20two%20drugs%20with%20a%20new%20mechanism%20of%20action%2C%20bedaquiline%20and%20delamanid%2C%20have%20been%20approved%20by%20stringent%20regulatory%20authorities%20and%20are%20recommended%20by%20the%20WHO.%20This%20narrative%20review%20summarizes%20the%20evidence%2C%20originating%20from%20both%20observational%20studies%20and%20clinical%20trials%2C%20which%20is%20available%20to%20support%20the%20use%20of%20these%20drugs%2C%20with%20a%20focus%20on%20special%20populations.%20Areas%20of%20uncertainty%2C%20including%20the%20use%20of%20the%20two%20drugs%20together%20or%20for%20prolonged%20duration%2C%20are%20discussed.%20Ongoing%20clinical%20trials%20are%20aiming%20to%20optimize%20the%20use%20of%20bedaquiline%20and%20delamanid%20to%20shorten%20the%20treatment%20of%20drug-resistant%20TB.%22%2C%22date%22%3A%222020-06%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.2217%5C%2Ffmb-2019-0309%22%2C%22ISSN%22%3A%221746-0913%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.futuremedicine.com%5C%2Fdoi%5C%2F10.2217%5C%2Ffmb-2019-0309%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A51%3A42Z%22%7D%7D%2C%7B%22key%22%3A%22A5YEI5ZD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jaffr%5Cu00e9%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJaffr%26%23xE9%3B%2C%20J.%2C%20Aubry%2C%20A.%2C%20Maitre%2C%20T.%2C%20Morel%2C%20F.%2C%20Brossier%2C%20F.%2C%20Robert%2C%20J.%2C%20Sougakoff%2C%20W.%2C%20Veziris%2C%20N.%20and%20the%20CNR-MyRMA%20%28Centre%20National%20de%20R%26%23xE9%3Bf%26%23xE9%3Brence%20des%20Mycobact%26%23xE9%3Bries%20et%20de%20la%20R%26%23xE9%3Bsistance%20des%20Mycobact%26%23xE9%3Bries%20aux%20Antituberculeux%29%20%282020%29.%20%3Cb%3ERational%20Choice%20of%20Antibiotics%20and%20Media%20for%20Mycobacterium%20avium%20Complex%20Drug%20Susceptibility%20Testing%3C%5C%2Fb%3E.%20Frontiers%20in%20Microbiology%20%3Ci%3E11%3C%5C%2Fi%3E%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmicb.2020.00081%27%3Ehttps%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmicb.2020.00081%3C%5C%2Fa%3E%20%5BAccessed%20March%202022%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rational%20Choice%20of%20Antibiotics%20and%20Media%20for%20Mycobacterium%20avium%20Complex%20Drug%20Susceptibility%20Testing%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00e9my%22%2C%22lastName%22%3A%22Jaffr%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22the%20CNR-MyRMA%20%28Centre%20National%20de%20R%5Cu00e9f%5Cu00e9rence%20des%20Mycobact%5Cu00e9ries%20et%20de%20la%20R%5Cu00e9sistance%20des%20Mycobact%5Cu00e9ries%20aux%20Antituberculeux%29%22%2C%22lastName%22%3A%22%22%7D%5D%2C%22abstractNote%22%3A%22The%20Clinical%20and%20Laboratory%20Standards%20Institute%20recommends%20the%20use%20of%20Mueller%20Hinton%20%28MH%29%20medium%20to%20perform%20drug%20susceptibility%20testing%20%28DST%29%20of%20Mycobacterium%20avium%20complex%20%28MAC%29%20using%20the%20microdilution%20method.%20For%20MAC%2C%20there%20has%20been%20no%20study%20on%20the%20impact%20of%20media%20on%20the%20determination%20of%20minimum%20inhibitory%20concentrations%20%28MICs%29%20of%20antibiotics%20other%20than%20clarithromycin.%20This%20study%20aimed%20at%20determining%20the%20impact%20of%20two%20media%20used%20for%20DST%20of%20MAC%20and%20at%20augmenting%20the%20number%20of%20pertinent%20MICs%20for%20MAC%20species%20encountered%20in%20clinical%20practice.%20MICs%20of%20antibiotics%20used%20for%20the%20treatment%20of%20MAC%20infections%20were%20determined%20for%20158%20clinical%20MAC%20isolates%20%2880%20M.%20avium%2C%2040%20M.%20intracellulare%2C%2035%20M.%20chimaera%2C%20two%20M.%20yongonense%20and%20one%20M.%20timonense%29%20in%20MH%20and%207H9%20broths%20using%20the%20SLOMYCO%20SensititreTM%20system%20%28TREK%20Diagnostic%20Systems%2C%20East%20Grinstead%2C%20United%20Kingdom%29.%20The%20modal%20MICs%20determined%20in%20both%20media%20were%20the%20same%20for%20linezolid%2C%20moxifloxacin%2C%20rifabutin%20and%20amikacin%20but%20not%20for%20clarithromycin%2C%20rifampin%20and%20ethambutol.%20The%20kappa%20test%20for%20MICs%20converted%20to%20susceptibility%20categories%20showed%20an%20excellent%20agreement%20for%20clarithromycin%2C%20a%20moderate%20agreement%20for%20linezolid%20and%20a%20weak%20agreement%20for%20moxifloxacin%20and%20amikacin.%20For%20amikacin%2C%207H9%20allowed%20a%20better%20distinction%20%28fewer%20intermediate%20strains%29%20of%20wild-type%20populations%20than%20MH.%20Existing%20breakpoints%20for%20linezolid%20and%20moxifloxacin%20are%20spread%20through%20the%20distribution%20of%20MICs%20for%20wild-type%20populations.%20The%20only%20breakpoints%20that%20can%20be%20used%20rationally%20are%20those%20for%20amikacin%20and%20clarithromycin.%20For%20amikacin%2C%207H9%20performs%20better%20than%20MH%2C%20whereas%20both%20media%20perform%20equally%20for%20clarithromycin.%20Given%20that%20testing%20in%207H9%2C%20as%20opposed%20to%20MH%2C%20allows%20easier%20MIC%20measurements%20and%20yields%20greater%20reproducibility%2C%20we%20propose%20the%20use%20of%207H9%20medium%20for%20DST%20of%20MAC.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%221664-302X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmicb.2020.00081%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A50%3A36Z%22%7D%7D%2C%7B%22key%22%3A%228RHGCVDE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Jaspard%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EJaspard%2C%20M.%2C%20Butel%2C%20N.%2C%20Helali%2C%20N.%20E.%2C%20Marigot-Outtandy%2C%20D.%2C%20Guillot%2C%20H.%2C%20Peytavin%2C%20G.%2C%20Veziris%2C%20N.%2C%20Bodaghi%2C%20B.%2C%20Flandre%2C%20P.%2C%20Petitjean%2C%20G.%2C%20Caumes%2C%20E.%20and%20Pourcher%2C%20V.%20%282020%29.%20%3Cb%3ELinezolid-Associated%20Neurologic%20Adverse%20Events%20in%20Patients%20with%20Multidrug-Resistant%20Tuberculosis%2C%20France%3C%5C%2Fb%3E.%20Emerg%20Infec%20Dis%20%3Ci%3E26%3C%5C%2Fi%3E%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2608.191499%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3201%5C%2Feid2608.191499%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Linezolid-Associated%20Neurologic%20Adverse%20Events%20in%20Patients%20with%20Multidrug-Resistant%20Tuberculosis%2C%20France%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Jaspard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Butel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Najoua%20El%22%2C%22lastName%22%3A%22Helali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helene%22%2C%22lastName%22%3A%22Guillot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Peytavin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bahram%22%2C%22lastName%22%3A%22Bodaghi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Flandre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregoire%22%2C%22lastName%22%3A%22Petitjean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Valerie%22%2C%22lastName%22%3A%22Pourcher%22%7D%5D%2C%22abstractNote%22%3A%22Linezolid-Associated%20Neurologic%20Adverse%20Events%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22en-us%22%2C%22DOI%22%3A%2210.3201%5C%2Feid2608.191499%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwwwnc.cdc.gov%5C%2Feid%5C%2Farticle%5C%2F26%5C%2F8%5C%2F19-1499_article%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T21%3A19%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22GKLI5KWR%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kort%20et%20al.%22%2C%22parsedDate%22%3A%222020-09-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKort%2C%20F.%2C%20Ray%2C%20L.%20F.%20L.%2C%20Chauffour%2C%20A.%2C%20Jarlier%2C%20V.%2C%20Lounis%2C%20N.%2C%20Andries%2C%20K.%2C%20Aubry%2C%20A.%2C%20Guglielmetti%2C%20L.%20and%20Veziris%2C%20N.%20%282020%29.%20%3Cb%3EFully%20weekly%20antituberculosis%20regimen%3A%20a%20proof-of-concept%20study%3C%5C%2Fb%3E.%20European%20Respiratory%20Journal%20%3Ci%3E56%3C%5C%2Fi%3E%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.02502-2019%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.02502-2019%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Fully%20weekly%20antituberculosis%20regimen%3A%20a%20proof-of-concept%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatma%22%2C%22lastName%22%3A%22Kort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laure%20Fournier%20Le%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nacer%22%2C%22lastName%22%3A%22Lounis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koen%22%2C%22lastName%22%3A%22Andries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Background%20The%20World%20Health%20Organization%20recommends%20supervising%20the%20treatment%20of%20tuberculosis.%20Intermittent%20regimens%20have%20the%20potential%20to%20simplify%20the%20supervision%20and%20improve%20compliance.%20Our%20objective%20was%20to%20analyse%20the%20sterilising%20activity%20of%20once-weekly%20regimens%20based%20on%20drugs%20with%20a%20long%20half-life%2C%20bedaquiline%20and%20rifapentine%2C%20in%20a%20murine%20model%20of%20tuberculosis.%5CnMethods%20300%20Swiss%20mice%20were%20infected%20intravenously%20infected%20with%20%5Cu00d710%5Cu22126%20CFU%20Mycobacterium%20tuberculosis%20H37Rv.%20Mice%20were%20treated%20once%20weekly%20with%20regimens%20containing%3A%201%29%20bedaquiline%2C%20rifapentine%20and%20pyrazinamide%20%28BPZ%29%3B%202%29%20BPZ%20plus%20moxifloxacin%20%28BPZM%29%3B%203%29%20BPZM%20plus%20clofazimine%20%28BPZMC%29%3B%204%29%20the%20standard%20daily%20regimen%20of%20tuberculosis.%20All%20regimens%20were%20given%20for%204%20or%206%20months.%20Bactericidal%20and%20sterilising%20activity%20were%20assessed.%5CnResults%20After%202%20months%20of%20treatment%2C%20the%20mean%20count%20in%20lungs%20was%200.76%5Cu00b10.60%20log10%20CFU%20in%20mice%20treated%20with%20the%20daily%20control%20regimen%20and%20negative%20in%20all%20mice%20treated%20with%20once-weekly%20regimens%20%28p%3C0.05%20compared%20to%20the%20daily%20control%29.%20All%20mice%20had%20negative%20lung%20cultures%20on%20completion%20of%20either%204%20or%206%20months%20of%20treatment%2C%20whereas%203%20months%20after%204%20and%206%20months%20of%20treatment%2C%20respectively%2C%20the%20relapse%20rate%20was%2064%25%20and%2013%25%20in%20the%20standard%20daily%20regimen%2C%205%25%20and%200%25%20in%20BPZ%2C%200%25%20and%200%25%20in%20BPMZ%20and%200%25%20and%205%25%20in%20BPMZC%20%28p%3C0.05%20for%20all%20once-weekly%20regimens%20versus%204-month%20daily%20control%3B%20p%3E0.05%20for%20all%20once-weekly%20regimens%20versus%206-month%20daily%20control%29.%5CnConclusions%20BPZ-based%20once-weekly%20regimens%20have%20higher%20sterilising%20activity%20than%20the%20standard%20daily%20regimen%20and%20could%20greatly%20simplify%20treatment%20administration%20and%20possibly%20shorten%20the%20duration%20of%20tuberculosis%20treatment.%5CnTweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetBedaquiline%5Cu2013rifapentine%5Cu2013pyrazinamide-based%20once-weekly%20regimens%20have%20higher%20sterilising%20activity%20than%20the%20standard%20daily%20regimen%20of%20tuberculosis%20and%20could%20thus%20greatly%20simplify%20treatment%20of%20tuberculosis%20https%3A%5C%2F%5C%2Fbit.ly%5C%2F2W8yx2r%22%2C%22date%22%3A%222020%5C%2F09%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.02502-2019%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F56%5C%2F3%5C%2F1902502%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A52%3A09Z%22%7D%7D%2C%7B%22key%22%3A%22AH5F39GE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lan%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELan%2C%20Zhiyi%2C%20Ahmad%2C%20Nafees%2C%20Baghaei%2C%20Parvaneh%2C%20Barkane%2C%20Linda%2C%20Benedetti%2C%20Andrea%2C%20Brode%2C%20Sarah%20K.%2C%20Brust%2C%20James%20C.%20M.%2C%20Campbell%2C%20Jonathon%20R.%2C%20Chang%2C%20Vicky%20Wai%20Lai%2C%20Falzon%2C%20Dennis%2C%20Guglielmetti%2C%20Lorenzo%2C%20Isaakidis%2C%20Petros%2C%20Kempker%2C%20Russell%20R.%2C%20Kipiani%2C%20Maia%2C%20Kuksa%2C%20Liga%2C%20Lange%2C%20Christoph%2C%20Laniado-Labor%26%23xED%3Bn%2C%20Rafael%2C%20Nahid%2C%20Payam%2C%20Rodrigues%2C%20Denise%2C%20Singla%2C%20Rupak%2C%20Udwadia%2C%20Zarir%20F.%2C%20Menzies%2C%20Dick%2C%20Ahmad%2C%20N.%2C%20Baghaei%2C%20P.%2C%20Barkane%2C%20L.%2C%20Benedetti%2C%20A.%2C%20Brode%2C%20S.%20K.%2C%20Brust%2C%20J.%20C.%20M.%2C%20Campbell%2C%20J.%20R.%2C%20Chang%2C%20V.%20W.%20L.%2C%20Falzon%2C%20D.%2C%20Guglielmetti%2C%20L.%2C%20Isaakidis%2C%20P.%2C%20Kempker%2C%20R.%20R.%2C%20Kipiani%2C%20M.%2C%20Kuksa%2C%20L.%2C%20Lan%2C%20Z.%2C%20Lange%2C%20C.%2C%20Laniado-Labor%26%23xED%3Bn%2C%20R.%2C%20Nahid%2C%20P.%2C%20Rodrigues%2C%20D.%2C%20Singla%2C%20R.%2C%20Udwadia%2C%20Z.%20F.%20and%20Menzies%2C%20D.%20%282020%29.%20%3Cb%3EDrug-associated%20adverse%20events%20in%20the%20treatment%20of%20multidrug-resistant%20tuberculosis%3A%20an%20individual%20patient%20data%20meta-analysis%3C%5C%2Fb%3E.%20The%20Lancet%20Respiratory%20Medicine%20%3Ci%3E8%3C%5C%2Fi%3E%2C%20383%26%23x2013%3B394%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2820%2930047-3%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2213-2600%2820%2930047-3%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Drug-associated%20adverse%20events%20in%20the%20treatment%20of%20multidrug-resistant%20tuberculosis%3A%20an%20individual%20patient%20data%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiyi%22%2C%22lastName%22%3A%22Lan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nafees%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parvaneh%22%2C%22lastName%22%3A%22Baghaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Barkane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20K.%22%2C%22lastName%22%3A%22Brode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C.%20M.%22%2C%22lastName%22%3A%22Brust%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathon%20R.%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vicky%20Wai%20Lai%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dennis%22%2C%22lastName%22%3A%22Falzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petros%22%2C%22lastName%22%3A%22Isaakidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20R.%22%2C%22lastName%22%3A%22Kempker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maia%22%2C%22lastName%22%3A%22Kipiani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%22%2C%22lastName%22%3A%22Laniado-Labor%5Cu00edn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denise%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupak%22%2C%22lastName%22%3A%22Singla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%20F.%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Baghaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Barkane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20K.%22%2C%22lastName%22%3A%22Brode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20C.%20M.%22%2C%22lastName%22%3A%22Brust%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20R.%22%2C%22lastName%22%3A%22Campbell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20W.%20L.%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Falzon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Isaakidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20R.%22%2C%22lastName%22%3A%22Kempker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Kipiani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%22%2C%22lastName%22%3A%22Lan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Laniado-Labor%5Cu00edn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Rodrigues%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Singla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Z.%20F.%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Menzies%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-04-01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2FS2213-2600%2820%2930047-3%22%2C%22ISSN%22%3A%222213-2600%2C%202213-2619%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.thelancet.com%5C%2Fjournals%5C%2Flanres%5C%2Farticle%5C%2FPIIS2213-2600%2820%2930047-3%5C%2Ffulltext%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A58%3A33Z%22%7D%7D%2C%7B%22key%22%3A%22PKC5HTPG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lecorche%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELecorche%2C%20E.%2C%20Pean%20de%20Ponfilly%2C%20G.%2C%20Mougari%2C%20F.%2C%20Benmansour%2C%20H.%2C%20Poisnel%2C%20E.%2C%20Janvier%2C%20F.%20and%20Cambau%2C%20E.%20%282020%29.%20%3Cb%3EDisseminated%20Mycobacterium%20chimaera%20Following%20Open-Heart%20Surgery%2C%20the%20Heater%26%23x2013%3BCooler%20Unit%20Worldwide%20Outbreak%3A%20Case%20Report%20and%20Minireview%3C%5C%2Fb%3E.%20Frontiers%20in%20Medicine%20%3Ci%3E7%3C%5C%2Fi%3E%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmed.2020.00243%27%3Ehttps%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmed.2020.00243%3C%5C%2Fa%3E%20%5BAccessed%20March%202022%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Disseminated%20Mycobacterium%20chimaera%20Following%20Open-Heart%20Surgery%2C%20the%20Heater%5Cu2013Cooler%20Unit%20Worldwide%20Outbreak%3A%20Case%20Report%20and%20Minireview%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Lecorche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gauthier%22%2C%22lastName%22%3A%22Pean%20de%20Ponfilly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanaa%22%2C%22lastName%22%3A%22Benmansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elodie%22%2C%22lastName%22%3A%22Poisnel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederic%22%2C%22lastName%22%3A%22Janvier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Invasive%20cardiovascular%20infections%20by%20Mycobacterium%20chimaera%20associated%20with%20open-heart%20surgery%20have%20been%20reported%20worldwide%20since%202013.%20Here%2C%20we%20report%20a%20case%20of%20a%2061%20year%20old%20man%2C%20without%20any%20other%20particular%20medical%20background%2C%20who%20underwent%20cardiac%20surgery%20for%20replacing%20part%20of%20the%20ascending%20aorta%20by%20a%20bio-prosthetic%20graft.%20Eighteen%20months%20later%2C%20the%20patient%20was%20painful%20at%20the%20lower%20back%20with%20fever.%20A%20pyogenic%20vertebral%20osteomyelitis%20due%20to%20M.%20chimaera%20associated%20to%20graft%20infection%20was%20diagnosed%20after%206%20months%20of%20sub-acute%20infection.%20The%20patient%20presented%20a%20disseminated%20disease%20with%20cerebral%20lesions%2C%20chorioretinitis%2C%20and%20chronic%20renal%20failure.%20Despite%20adequate%20antimicrobial%20treatment%20and%20graft%20explantation%2C%20the%20patient%20died%20after%206%20years.%20We%20reviewed%20the%20literature%20on%20M.%20chimaera%20infections%20associated%20with%20open-heart%20surgery.%20The%20worldwide%20outbreak%20has%20been%20explained%20by%20airborne%20bioaerosol%20generated%20by%20the%203T%20heater%5Cu2013cooler%20unit%20%28HCU%29%20used%20during%20cardiac%20by-pass%20surgical%20procedures.%20These%20infections%20are%20difficult%20to%20diagnose%20because%20of%20a%20long%20latency%20period%20%28up%20to%20several%20years%29%2C%20with%20no%20specific%20symptoms%20and%20a%20highly%20specialized%20microbiological%20diagnosis.%20The%20treatment%20is%20based%20on%20antibiotics%20and%20surgery.%20These%20infections%20are%20also%20difficult%20to%20treat%2C%20since%20the%20mortality%20rate%20is%20high%20around%2050%25.%20Prevention%20is%20necessary%20by%20modifying%20the%20use%20of%20HCUs%20in%20operating%20rooms.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222296-858X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffmed.2020.00243%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A53%3A38Z%22%7D%7D%2C%7B%22key%22%3A%22YCXT4KPC%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lerolle%20et%20al.%22%2C%22parsedDate%22%3A%222020-01-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELerolle%2C%20N.%2C%20Laanani%2C%20M.%2C%20Galicier%2C%20L.%2C%20Rivi%26%23xE8%3Bre%2C%20S.%2C%20Meynard%2C%20J.-L.%2C%20Azoulay%2C%20E.%2C%20Jeblaoui%2C%20A.%2C%20Lalande%2C%20V.%2C%20Mougari%2C%20F.%2C%20Fardet%2C%20L.%2C%20Coppo%2C%20P.%2C%20Goujard%2C%20C.%2C%20Molina%2C%20J.-M.%20and%20Lambotte%2C%20O.%20%282020%29.%20%3Cb%3EFactors%20associated%20with%20tuberculosis-associated%20haemophagocytic%20syndrome%3A%20a%20multicentre%20case-control%20study%3C%5C%2Fb%3E.%20The%20International%20Journal%20of%20Tuberculosis%20and%20Lung%20Disease%20%3Ci%3E24%3C%5C%2Fi%3E%2C%20124%26%23x2013%3B130%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.19.0856%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.5588%5C%2Fijtld.19.0856%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Factors%20associated%20with%20tuberculosis-associated%20haemophagocytic%20syndrome%3A%20a%20multicentre%20case-control%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Lerolle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Laanani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Galicier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Rivi%5Cu00e8re%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J-L.%22%2C%22lastName%22%3A%22Meynard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Azoulay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Jeblaoui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Lalande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Fardet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Coppo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Goujard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J-M.%22%2C%22lastName%22%3A%22Molina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Lambotte%22%7D%5D%2C%22abstractNote%22%3A%22SETTING%3A%20Tuberculosis%20%28TB%29%20is%20a%20potential%20trigger%20of%20haemophagocytic%20syndrome%20%28HS%29%20but%20little%20is%20known%20about%20the%20features%20of%20TB-associated%20HS.%5CnOBJECTIVE%3A%20To%20assess%20the%20risk%20factors%20associated%20with%20HS%20in%20patients%20with%20TB.%5CnDESIGN%3A%20We%20performed%20a%20multicentre%5Cncase-control%20study%20assessing%20the%20medical%20records%20of%20adult%20patients%20diagnosed%20with%20proven%20TB%20with%20%28TB%5C%2FHS%2B%29%20or%20without%20%28TB%5C%2FHS%5Cu2013%29%20associated%20HS.%5CnRESULTS%3A%20Twenty-one%20patients%20with%20TB%5C%2FHS%2B%20%2824%25%20women%2C%20median%20age%2C%2037%20years%20%5BIQR%2030%5Cu201348%5D%29%20were%20included%20in%20the%20study.%20Eleven%20patients%5Cn%2852%25%29%20were%20infected%20with%20human%20immunodeficiency%20virus%20and%20seven%20patients%20%2833%25%29%20were%20immunocompromised%20due%20to%20other%20reasons.%20TB%20was%20disseminated%20in%2017%20patients%20%2881%25%29.%20Compared%20with%2050%20control%20TB%20patients%20%28TB%5C%2FHS%5Cu2013%29%2C%20patients%20with%20TB%5C%2FHS%2B%20were%20more%20likely%20to%20be%20immunocompromised%20%2886%25%20vs.%5Cn18%25%3B%20P%20%3C%200.001%29%20and%20to%20present%20with%20disseminated%20TB%20%2880%25%20vs.%2012%25%3B%20P%20%3C%200.001%29.%20The%20outcome%20was%20poorer%20in%20patients%20with%20TB%5C%2FHS%2B%2C%20with%20a%20higher%20admission%20rate%20to%20intensive%20care%20%2871%25%20vs.%200%25%3B%20P%20%3C%200.001%29%20and%20a%20higher%20risk%20of%20death%20%2838%25%20vs.%207%25%3B%20P%20%3D%200.005%29.%5CnCONCLUSION%3A%5CnTB%5C%2FHS%2B%20occurred%20more%20likely%20in%20immunocompromised%20patients%20and%20severely%20impaired%20the%20prognosis%20of%20TB.%20Further%20studies%20are%20needed%20to%20devise%20therapeutic%20strategies%20for%20patients%20with%20TB%5C%2FHS%2B.%22%2C%22date%22%3A%222020-01-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.5588%5C%2Fijtld.19.0856%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-05-16T15%3A17%3A28Z%22%7D%7D%2C%7B%22key%22%3A%222BNB896G%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lopes%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELopes%2C%20A.%2C%20Mougari%2C%20F.%2C%20Chopin%2C%20D.%2C%20Pogliaghi%2C%20M.%2C%20Munier%2C%20A.%2C%20Delcey%2C%20V.%2C%20Simoneau%2C%20G.%2C%20Raskine%2C%20L.%2C%20Evans%2C%20J.%2C%20Mouly%2C%20S.%2C%20Cambau%2C%20E.%2C%20Bergmann%2C%20J.%20and%20Sellier%2C%20P.%20%282020%29.%20%3Cb%3EProspective%20study%20comparing%20the%20conventional%20and%20same-day%20strategies%20to%20diagnose%20pulmonary%20tuberculosis%20-%20ScienceDirect%3C%5C%2Fb%3E.%20Med%20Mal%20Infect%20%3Ci%3E50%3C%5C%2Fi%3E%2C%2036%26%23x2013%3B42%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X18301343%3Fvia%253Dihub%27%3Ehttps%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X18301343%3Fvia%253Dihub%3C%5C%2Fa%3E%20%5BAccessed%20March%202022%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prospective%20study%20comparing%20the%20conventional%20and%20same-day%20strategies%20to%20diagnose%20pulmonary%20tuberculosis%20-%20ScienceDirect%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Lopes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D%22%2C%22lastName%22%3A%22Chopin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M%22%2C%22lastName%22%3A%22Pogliaghi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AL%22%2C%22lastName%22%3A%22Munier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V%22%2C%22lastName%22%3A%22Delcey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G%22%2C%22lastName%22%3A%22Simoneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Evans%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Mouly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JF%22%2C%22lastName%22%3A%22Bergmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P%22%2C%22lastName%22%3A%22Sellier%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X18301343%3Fvia%253Dihub%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T21%3A15%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22WJXYWJXE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Marsollier%20et%20al.%22%2C%22parsedDate%22%3A%222020-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMarsollier%2C%20L.%2C%20Aubry%2C%20A.%2C%20Carbonnelle%2C%20E.%2C%20Canaan%2C%20S.%2C%20Laencina%2C%20L.%2C%20Cambau%2C%20E.%20and%20Herrmann%2C%20J.%20%282020%29.%20%3Cb%3EMycobact%26%23xE9%3Brioses%20cutan%26%23xE9%3Bes%20dues%20%26%23xE0%3B%20Mycobacterium%20ulcerans%2C%20Mycobacterium%20marinum%2C%20Mycobacterium%20abscessus%2C%20Mycobacterium%20chelonae%20et%20autres%20mycobact%26%23xE9%3Bries%20non%20tuberculeuses%3C%5C%2Fb%3E.%20EM-Consulte%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1166-8598%2819%2981974-9%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1166-8598%2819%2981974-9%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Mycobact%5Cu00e9rioses%20cutan%5Cu00e9es%20dues%20%5Cu00e0%20Mycobacterium%20ulcerans%2C%20Mycobacterium%20marinum%2C%20Mycobacterium%20abscessus%2C%20Mycobacterium%20chelonae%20et%20autres%20mycobact%5Cu00e9ries%20non%20tuberculeuses%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Marsollier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Carbonnelle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%22%2C%22lastName%22%3A%22Canaan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L%22%2C%22lastName%22%3A%22Laencina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22JL%22%2C%22lastName%22%3A%22Herrmann%22%7D%5D%2C%22abstractNote%22%3A%22Mycobact%5Cu00e9rioses%20cutan%5Cu00e9es%20dues%20%5Cu00e0%20%3Ci%3EMycobacterium%20ulcerans%3C%5C%2Fi%3E%2C%20%3Ci%3EMycobacterium%20marinum%3C%5C%2Fi%3E%2C%20%3Ci%3EMycobacterium%20abscessus%3C%5C%2Fi%3E%2C%20%3Ci%3EMycobacterium%20chelonae%3C%5C%2Fi%3E%20et%20autres%20mycobact%5Cu00e9ries%20non%20tuberculeuses%22%2C%22date%22%3A%2203%5C%2F01%5C%2F2020%22%2C%22language%22%3A%22fr%22%2C%22DOI%22%3A%2210.1016%5C%2FS1166-8598%2819%2981974-9%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.em-consulte.com%5C%2Farticle%5C%2F1342652%5C%2Fmycobacterioses-cutanees-dues-a-mycobacterium-ulce%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T09%3A26%3A56Z%22%7D%7D%2C%7B%22key%22%3A%22SCZA6SEA%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22M%5Cu00e9cha%5Cu00ef%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EM%26%23xE9%3Bcha%26%23xEF%3B%2C%20F.%2C%20Cordel%2C%20H.%2C%20Guglielmetti%2C%20L.%2C%20Aubry%2C%20A.%2C%20Jankovic%2C%20M.%2C%20Viveiros%2C%20M.%2C%20Santin%2C%20M.%2C%20Goletti%2C%20D.%20and%20Cambau%2C%20E.%20%282020%29.%20%3Cb%3EManagement%20of%20Tuberculosis%3A%20Are%20the%20Practices%20Homogeneous%20in%20High-Income%20Countries%3F%3C%5C%2Fb%3E%20Frontiers%20in%20Public%20Health%20%3Ci%3E8%3C%5C%2Fi%3E%2C%20URL%3A%20%3Ca%20target%3D%27_blank%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffpubh.2020.00443%27%3Ehttps%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffpubh.2020.00443%3C%5C%2Fa%3E%20%5BAccessed%20March%202022%5D.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Management%20of%20Tuberculosis%3A%20Are%20the%20Practices%20Homogeneous%20in%20High-Income%20Countries%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fr%5Cu00e9d%5Cu00e9ric%22%2C%22lastName%22%3A%22M%5Cu00e9cha%5Cu00ef%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hugues%22%2C%22lastName%22%3A%22Cordel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateja%22%2C%22lastName%22%3A%22Jankovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Santin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delia%22%2C%22lastName%22%3A%22Goletti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%3A%20To%20evaluate%20and%20compare%20practices%20regarding%20the%20diagnosis%2C%20isolation%20measures%2C%20and%20treatment%20of%20tuberculosis%20%28TB%29%20in%20high-income%20countries%20and%20mainly%20in%20Europe.Materials%20and%20Methods%3A%20A%20survey%20was%20conducted%20from%20November%202018%20to%20April%202019%20within%20the%20European%20Society%20of%20Clinical%20Microbiology%20and%20Infectious%20Diseases%20Study%20Group%20for%20Mycobacterial%20Infections%20%28ESGMYC%29.%20The%20practices%20observed%20were%20compared%20to%20the%20main%20international%20guidelines.Results%3A%20Among%20136%20ESGMYC%20members%2C%2064%20%2817%20countries%29%20responded%20to%20the%20questionnaire.%20In%20their%20practice%2C%20two%20%2820.7%25%29%20or%20three%20sputum%20samples%20%2879.3%25%29%20were%20collected%20for%20the%20diagnosis%20of%20pulmonary%20TB%2C%20alternatively%20induced%20sputum%20%28n%20%3D%2037%2C%2067.2%25%29%2C%20bronchoscopy%20%2834%2C%2058.6%25%29%2C%20and%20gastric%20aspirates%20%2815%2C%2025.9%25%29.%20Nucleic%20acid%20amplification%20tests%20%28NAATs%29%20were%20performed%20by%2041%20%2864%25%29%20respondents%20whatever%20the%20smear%20result%20and%20by%2047%20%2873%25%29%20in%20case%20of%20smear-positive%20specimens.%20NAAT%20and%20adenosine%20deaminase%20measurement%20were%20used%20for%20extrapulmonary%20TB%20diagnosis%20in%2083.6%20and%2040.4%25%20of%20cases%2C%20respectively.%20For%20isolation%20duration%2C%2021%20respondents%20%2842.9%25%29%20were%20keeping%20isolation%20until%20smear%20negativity.%20An%20initial%20treatment%20without%20ethambutol%20was%20offered%20by%2014%25%20%28n%20%3D%209%29%20of%20respondents.%20Corticosteroid%20therapy%2C%20cerebrospinal%20fluid%20opening%20pressure%20testing%2C%20and%20repeated%20lumbar%20puncture%20were%20carried%20out%20for%20central%20nervous%20system%20TB%20by%2079.6%2C%2051.9%2C%20and%2046.3%25%20of%20the%20respondents%2C%20respectively.%20For%20patients%20with%20human%20immunodeficiency%20virus%5Cu2013TB%20coinfection%2C%20the%20preferred%20antiretroviral%20therapy%20included%20dolutegravir%2050%20mg%20twice%20a%20day%20%2856.8%25%29.%20Comparing%20with%20the%20recommendations%20of%20the%20main%20guidelines%2C%20the%20practices%20are%20not%20totally%20consistent.Conclusion%3A%20This%20study%20shows%20heterogeneous%20practices%2C%20particularly%20for%20diagnosis%2C%20and%20isolation%2C%20although%20rapid%20molecular%20testing%20is%20implemented%20in%20most%20centers.%20More%20standardization%20might%20be%20needed.%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22ISSN%22%3A%222296-2565%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticle%5C%2F10.3389%5C%2Ffpubh.2020.00443%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A52%3A24Z%22%7D%7D%2C%7B%22key%22%3A%22S5E6NTSJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Morel%20et%20al.%22%2C%22parsedDate%22%3A%222020%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMorel%2C%20F.%2C%20Jaffr%26%23xE9%3B%2C%20J.%2C%20Sougakoff%2C%20W.%2C%20Aubry%2C%20A.%20and%20V%26%23xE9%3Bziris%2C%20N.%20%282020%29.%20%3Cb%3EPlace%20de%20la%20biologie%20mol%26%23xE9%3Bculaire%20dans%20le%20diagnostic%20de%20la%20tuberculose%3C%5C%2Fb%3E.%20Revue%20des%20Maladies%20Respiratoires%20%3Ci%3E37%3C%5C%2Fi%3E%2C%20412%26%23x2013%3B416%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2019.09.004%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2019.09.004%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Place%20de%20la%20biologie%20mol%5Cu00e9culaire%20dans%20le%20diagnostic%20de%20la%20tuberculose%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Morel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00e9my%22%2C%22lastName%22%3A%22Jaffr%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandra%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22V%5Cu00e9ziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2019.09.004%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fhal.sorbonne-universite.fr%5C%2Fhal-02880877%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-02-25T15%3A49%3A27Z%22%7D%7D%2C%7B%22key%22%3A%22TUTCESXE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ong%20et%20al.%22%2C%22parsedDate%22%3A%222020-10-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EOng%2C%20C.%20W.%20M.%2C%20Migliori%2C%20G.%20B.%2C%20Raviglione%2C%20M.%2C%20MacGregor-Skinner%2C%20G.%2C%20Sotgiu%2C%20G.%2C%20Alffenaar%2C%20J.-W.%2C%20Tiberi%2C%20S.%2C%20Adlhoch%2C%20C.%2C%20Alonzi%2C%20T.%2C%20Archuleta%2C%20S.%2C%20Brusin%2C%20S.%2C%20Cambau%2C%20E.%2C%20Capobianchi%2C%20M.%20R.%2C%20Castilletti%2C%20C.%2C%20Centis%2C%20R.%2C%20Cirillo%2C%20D.%20M.%2C%20D%26%23x2019%3BAmbrosio%2C%20L.%2C%20Delogu%2C%20G.%2C%20Esposito%2C%20S.%20M.%20R.%2C%20Figueroa%2C%20J.%2C%20Friedland%2C%20J.%20S.%2C%20Ho%2C%20B.%20C.%20H.%2C%20Ippolito%2C%20G.%2C%20Jankovic%2C%20M.%2C%20Kim%2C%20H.%20Y.%2C%20Klintz%2C%20S.%20R.%2C%20K%26%23xF6%3Bdm%26%23xF6%3Bn%2C%20C.%2C%20Lalle%2C%20E.%2C%20Leo%2C%20Y.%20S.%2C%20Leung%2C%20C.-C.%2C%20M%26%23xE4%3Brtson%2C%20A.-G.%2C%20Melazzini%2C%20M.%20G.%2C%20Fard%2C%20S.%20N.%2C%20Penttinen%2C%20P.%2C%20Petrone%2C%20L.%2C%20Petruccioli%2C%20E.%2C%20Pontali%2C%20E.%2C%20Saderi%2C%20L.%2C%20Santin%2C%20M.%2C%20Spanevello%2C%20A.%2C%20Crevel%2C%20R.%20van%2C%20Werf%2C%20M.%20J.%20van%20der%2C%20Visca%2C%20D.%2C%20Viveiros%2C%20M.%2C%20Zellweger%2C%20J.-P.%2C%20Zumla%2C%20A.%20and%20Goletti%2C%20D.%20%282020%29.%20%3Cb%3EEpidemic%20and%20pandemic%20viral%20infections%3A%20impact%20on%20tuberculosis%20and%20the%20lung%3A%20A%20consensus%20by%20the%20World%20Association%20for%20Infectious%20Diseases%20and%20Immunological%20Disorders%20%28WAidid%29%2C%20Global%20Tuberculosis%20Network%20%28GTN%29%2C%20and%20members%20of%20the%20European%20Society%20of%20Clinical%20Microbiology%20and%20Infectious%20Diseases%20Study%20Group%20for%20Mycobacterial%20Infections%20%28ESGMYC%29%3C%5C%2Fb%3E.%20European%20Respiratory%20Journal%20%3Ci%3E56%3C%5C%2Fi%3E%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01727-2020%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.01727-2020%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Epidemic%20and%20pandemic%20viral%20infections%3A%20impact%20on%20tuberculosis%20and%20the%20lung%3A%20A%20consensus%20by%20the%20World%20Association%20for%20Infectious%20Diseases%20and%20Immunological%20Disorders%20%28WAidid%29%2C%20Global%20Tuberculosis%20Network%20%28GTN%29%2C%20and%20members%20of%20the%20European%20Society%20of%20Clinical%20Microbiology%20and%20Infectious%20Diseases%20Study%20Group%20for%20Mycobacterial%20Infections%20%28ESGMYC%29%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%20Wei%20Min%22%2C%22lastName%22%3A%22Ong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%20Battista%22%2C%22lastName%22%3A%22Migliori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%22%2C%22lastName%22%3A%22Raviglione%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gavin%22%2C%22lastName%22%3A%22MacGregor-Skinner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Sotgiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan-Willem%22%2C%22lastName%22%3A%22Alffenaar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cornelia%22%2C%22lastName%22%3A%22Adlhoch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tonino%22%2C%22lastName%22%3A%22Alonzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophia%22%2C%22lastName%22%3A%22Archuleta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%22%2C%22lastName%22%3A%22Brusin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Rosaria%22%2C%22lastName%22%3A%22Capobianchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Concetta%22%2C%22lastName%22%3A%22Castilletti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosella%22%2C%22lastName%22%3A%22Centis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20M.%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lia%22%2C%22lastName%22%3A%22D%27Ambrosio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Delogu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susanna%20M.%20R.%22%2C%22lastName%22%3A%22Esposito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%22%2C%22lastName%22%3A%22Figueroa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jon%20S.%22%2C%22lastName%22%3A%22Friedland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20Choon%20Heng%22%2C%22lastName%22%3A%22Ho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giuseppe%22%2C%22lastName%22%3A%22Ippolito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateja%22%2C%22lastName%22%3A%22Jankovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20Yejin%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Senia%20Rosales%22%2C%22lastName%22%3A%22Klintz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Csaba%22%2C%22lastName%22%3A%22K%5Cu00f6dm%5Cu00f6n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eleonora%22%2C%22lastName%22%3A%22Lalle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yee%20Sin%22%2C%22lastName%22%3A%22Leo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi-Chiu%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne-Grete%22%2C%22lastName%22%3A%22M%5Cu00e4rtson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mario%20Giovanni%22%2C%22lastName%22%3A%22Melazzini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saeid%20Najafi%22%2C%22lastName%22%3A%22Fard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pasi%22%2C%22lastName%22%3A%22Penttinen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Petrone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Petruccioli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuele%22%2C%22lastName%22%3A%22Pontali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Saderi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Santin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Antonio%22%2C%22lastName%22%3A%22Spanevello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reinout%20van%22%2C%22lastName%22%3A%22Crevel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marieke%20J.%20van%20der%22%2C%22lastName%22%3A%22Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dina%22%2C%22lastName%22%3A%22Visca%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Pierre%22%2C%22lastName%22%3A%22Zellweger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alimuddin%22%2C%22lastName%22%3A%22Zumla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delia%22%2C%22lastName%22%3A%22Goletti%22%7D%5D%2C%22abstractNote%22%3A%22Major%20epidemics%2C%20including%20some%20that%20qualify%20as%20pandemics%2C%20such%20as%20severe%20acute%20respiratory%20syndrome%20%28SARS%29%2C%20Middle%20East%20respiratory%20syndrome%20%28MERS%29%2C%20HIV%2C%20influenza%20A%20%28H1N1%29pdm%5C%2F09%20and%20most%20recently%20COVID-19%2C%20affect%20the%20lung.%20Tuberculosis%20%28TB%29%20remains%20the%20top%20infectious%20disease%20killer%2C%20but%20apart%20from%20syndemic%20TB%5C%2FHIV%20little%20is%20known%20regarding%20the%20interaction%20of%20viral%20epidemics%20and%20pandemics%20with%20TB.%20The%20aim%20of%20this%20consensus-based%20document%20is%20to%20describe%20the%20effects%20of%20viral%20infections%20resulting%20in%20epidemics%20and%20pandemics%20that%20affect%20the%20lung%20%28MERS%2C%20SARS%2C%20HIV%2C%20influenza%20A%20%28H1N1%29pdm%5C%2F09%20and%20COVID-19%29%20and%20their%20interactions%20with%20TB.%20A%20search%20of%20the%20scientific%20literature%20was%20performed.%20A%20writing%20committee%20of%20international%20experts%20including%20the%20European%20Centre%20for%20Disease%20Prevention%20and%20Control%20Public%20Health%20Emergency%20%28ECDC%20PHE%29%20team%2C%20the%20World%20Association%20for%20Infectious%20Diseases%20and%20Immunological%20Disorders%20%28WAidid%29%2C%20the%20Global%20Tuberculosis%20Network%20%28GTN%29%2C%20and%20members%20of%20the%20European%20Society%20of%20Clinical%20Microbiology%20and%20Infectious%20Diseases%20%28ESCMID%29%20Study%20Group%20for%20Mycobacterial%20Infections%20%28ESGMYC%29%20was%20established.%20Consensus%20was%20achieved%20after%20multiple%20rounds%20of%20revisions%20between%20the%20writing%20committee%20and%20a%20larger%20expert%20group.%20A%20Delphi%20process%20involving%20the%20core%20group%20of%20authors%20%28excluding%20the%20ECDC%20PHE%20team%29%20identified%20the%20areas%20requiring%20review%5C%2Fconsensus%2C%20followed%20by%20a%20second%20round%20to%20refine%20the%20definitive%20consensus%20elements.%20The%20epidemiology%20and%20immunology%20of%20these%20viral%20infections%20and%20their%20interactions%20with%20TB%20are%20discussed%20with%20implications%20for%20diagnosis%2C%20treatment%20and%20prevention%20of%20airborne%20infections%20%28infection%20control%2C%20viral%20containment%20and%20workplace%20safety%29.%20This%20consensus%20document%20represents%20a%20rapid%20and%20comprehensive%20summary%20on%20what%20is%20known%20on%20the%20topic.%5CnTweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetThis%20consensus%20statement%20describes%20the%20effects%20of%20the%20viral%20infections%20resulting%20in%20epidemics%20and%20pandemics%20affecting%20the%20lung%20%28MERS%2C%20SARS%2C%20HIV%2C%20influenza%20A%20%28H1N1%29pdm%5C%2F09%20and%20COVID-19%29%20and%20their%20interactions%20with%20TB%2C%20the%20top%20infectious%20disease%20killer%20https%3A%5C%2F%5C%2Fbit.ly%5C%2F2UUjhGu%22%2C%22date%22%3A%222020%5C%2F10%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.01727-2020%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F56%5C%2F4%5C%2F2001727%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A53%3A47Z%22%7D%7D%2C%7B%22key%22%3A%22T9ZY5DEX%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Phillips%20et%20al.%22%2C%22parsedDate%22%3A%222020-04-18%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPhillips%2C%20R.%20O.%2C%20Robert%2C%20J.%2C%20Abass%2C%20K.%20M.%2C%20Thompson%2C%20W.%2C%20Sarfo%2C%20F.%20S.%2C%20Wilson%2C%20T.%2C%20Sarpong%2C%20G.%2C%20Gateau%2C%20T.%2C%20Chauty%2C%20A.%2C%20Omollo%2C%20R.%2C%20Ochieng%20Otieno%2C%20M.%2C%20Egondi%2C%20T.%20W.%2C%20Ampadu%2C%20E.%20O.%2C%20Agossadou%2C%20D.%2C%20Marion%2C%20E.%2C%20Ganlonon%2C%20L.%2C%20Wansbrough-Jones%2C%20M.%2C%20Grosset%2C%20J.%2C%20Macdonald%2C%20J.%20M.%2C%20Treadwell%2C%20T.%2C%20Saunderson%2C%20P.%2C%20Paintsil%2C%20A.%2C%20Lehman%2C%20L.%2C%20Frimpong%2C%20M.%2C%20Sarpong%2C%20N.%20F.%2C%20Saizonou%2C%20R.%2C%20Tiendrebeogo%2C%20A.%2C%20Ohene%2C%20S.-A.%2C%20Stienstra%2C%20Y.%2C%20Asiedu%2C%20K.%20B.%2C%20van%20der%20Werf%2C%20T.%20S.%2C%20Osei%20Mireku%2C%20S.%2C%20Abotsi%2C%20J.%2C%20Adu%20Poku%2C%20J.%20K.%2C%20Asamoah-Frimpong%2C%20R.%2C%20Osei-Wusu%2C%20B.%2C%20Sarpong%2C%20E.%2C%20Konadu%2C%20B.%2C%20Opoku%2C%20E.%2C%20Forson%2C%20M.%2C%20Ndogyele%2C%20M.%2C%20Ofori%2C%20E.%2C%20Aboagye%2C%20F.%2C%20Berko%2C%20T.%2C%20Amofa%2C%20G.%2C%20Nsiah%2C%20A.%2C%20Mensah-Bonsu%2C%20J.%2C%20Ofori%20Nyarko%2C%20J.%2C%20Amoako%2C%20Y.%20A.%2C%20Koranteng%20Tannor%2C%20E.%2C%20Boakye-Appiah%2C%20J.%2C%20Dzibordzi%20Loglo%2C%20A.%2C%20Sarpong-Duah%2C%20M.%2C%20Agbavor%2C%20B.%2C%20Ardent%2C%20M.%20F.%2C%20Yamadjako%2C%20A.%2C%20Adanmado%20Gersande%2C%20N.%2C%20Adeye%2C%20A.%2C%20Kindjinou%2C%20M.%2C%20Akpolan%2C%20Kiki%2C%20M.%2C%20Sodjinou%2C%20E.%2C%20Guegnard%2C%20C.%2C%20Klis%2C%20S.-A.%2C%20Velding%2C%20K.%2C%20Omansen%2C%20T.%2C%20Ofori-Adjei%2C%20D.%2C%20Eyangoh%2C%20S.%2C%20Knell%2C%20A.%20and%20Faber%2C%20W.%20%282020%29.%20%3Cb%3ERifampicin%20and%20clarithromycin%20%28extended%20release%29%20versus%20rifampicin%20and%20streptomycin%20for%20limited%20Buruli%20ulcer%20lesions%3A%20a%20randomised%2C%20open-label%2C%20non-inferiority%20phase%203%20trial%3C%5C%2Fb%3E.%20The%20Lancet%20%3Ci%3E395%3C%5C%2Fi%3E%2C%201259%26%23x2013%3B1267%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2820%2930047-7%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2820%2930047-7%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Rifampicin%20and%20clarithromycin%20%28extended%20release%29%20versus%20rifampicin%20and%20streptomycin%20for%20limited%20Buruli%20ulcer%20lesions%3A%20a%20randomised%2C%20open-label%2C%20non-inferiority%20phase%203%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20O%22%2C%22lastName%22%3A%22Phillips%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kabiru%20Mohamed%22%2C%22lastName%22%3A%22Abass%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fred%20Stephen%22%2C%22lastName%22%3A%22Sarfo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tuah%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Godfred%22%2C%22lastName%22%3A%22Sarpong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thierry%22%2C%22lastName%22%3A%22Gateau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annick%22%2C%22lastName%22%3A%22Chauty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%22%2C%22lastName%22%3A%22Omollo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Ochieng%20Otieno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thaddaeus%20W%22%2C%22lastName%22%3A%22Egondi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edwin%20O%22%2C%22lastName%22%3A%22Ampadu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Agossadou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Marion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Line%22%2C%22lastName%22%3A%22Ganlonon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Wansbrough-Jones%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Grosset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20M%22%2C%22lastName%22%3A%22Macdonald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Terry%22%2C%22lastName%22%3A%22Treadwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Saunderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Paintsil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Lehman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22Frimpong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nanaa%20Francisca%22%2C%22lastName%22%3A%22Sarpong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raoul%22%2C%22lastName%22%3A%22Saizonou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sally-Ann%22%2C%22lastName%22%3A%22Ohene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ymkje%22%2C%22lastName%22%3A%22Stienstra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kingsley%20B%22%2C%22lastName%22%3A%22Asiedu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tjip%20S%22%2C%22lastName%22%3A%22van%20der%20Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samuel%22%2C%22lastName%22%3A%22Osei%20Mireku%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justice%22%2C%22lastName%22%3A%22Abotsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20Ken%22%2C%22lastName%22%3A%22Adu%20Poku%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Asamoah-Frimpong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bright%22%2C%22lastName%22%3A%22Osei-Wusu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Sarpong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatrice%22%2C%22lastName%22%3A%22Konadu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernest%22%2C%22lastName%22%3A%22Opoku%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Forson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathias%22%2C%22lastName%22%3A%22Ndogyele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%22%2C%22lastName%22%3A%22Ofori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felicity%22%2C%22lastName%22%3A%22Aboagye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Berko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%22%2C%22lastName%22%3A%22Amofa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anastasia%22%2C%22lastName%22%3A%22Nsiah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joyce%22%2C%22lastName%22%3A%22Mensah-Bonsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Ofori%20Nyarko%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yaw%20Ampem%22%2C%22lastName%22%3A%22Amoako%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elliot%22%2C%22lastName%22%3A%22Koranteng%20Tannor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Justice%22%2C%22lastName%22%3A%22Boakye-Appiah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aloysius%22%2C%22lastName%22%3A%22Dzibordzi%20Loglo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mabel%22%2C%22lastName%22%3A%22Sarpong-Duah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bernadette%22%2C%22lastName%22%3A%22Agbavor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20Fran%5Cu00e7oise%22%2C%22lastName%22%3A%22Ardent%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arnaud%22%2C%22lastName%22%3A%22Yamadjako%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naomi%22%2C%22lastName%22%3A%22Adanmado%20Gersande%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ambroise%22%2C%22lastName%22%3A%22Adeye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martial%22%2C%22lastName%22%3A%22Kindjinou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Akpolan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maxime%22%2C%22lastName%22%3A%22Kiki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Espoir%22%2C%22lastName%22%3A%22Sodjinou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cl%5Cu00e9mence%22%2C%22lastName%22%3A%22Guegnard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandor-Adrian%22%2C%22lastName%22%3A%22Klis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristien%22%2C%22lastName%22%3A%22Velding%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Till%22%2C%22lastName%22%3A%22Omansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Ofori-Adjei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Eyangoh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alan%22%2C%22lastName%22%3A%22Knell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Faber%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnBuruli%20ulcer%20is%20a%20neglected%20tropical%20disease%20caused%20by%20Mycobacterium%20ulcerans%20infection%20that%20damages%20the%20skin%20and%20subcutis.%20It%20is%20most%20prevalent%20in%20western%20and%20central%20Africa%20and%20Australia.%20Standard%20antimicrobial%20treatment%20with%20oral%20rifampicin%2010%20mg%5C%2Fkg%20plus%20intramuscular%20streptomycin%2015%20mg%5C%2Fkg%20once%20daily%20for%208%20weeks%20%28RS8%29%20is%20highly%20effective%2C%20but%20streptomycin%20injections%20are%20painful%20and%20potentially%20harmful.%20We%20aimed%20to%20compare%20the%20efficacy%20and%20tolerability%20of%20fully%20oral%20rifampicin%2010%20mg%5C%2Fkg%20plus%20clarithromycin%2015%20mg%5C%2Fkg%20extended%20release%20once%20daily%20for%208%20weeks%20%28RC8%29%20with%20that%20of%20RS8%20for%20treatment%20of%20early%20Buruli%20ulcer%20lesions.%5CnMethods%5CnWe%20did%20an%20open-label%2C%20non-inferiority%2C%20randomised%20%281%3A1%20with%20blocks%20of%20six%29%2C%20multicentre%2C%20phase%203%20clinical%20trial%20comparing%20fully%20oral%20RC8%20with%20RS8%20in%20patients%20with%20early%2C%20limited%20Buruli%20ulcer%20lesions.%20There%20were%20four%20trial%20sites%20in%20hospitals%20in%20Ghana%20%28Agogo%2C%20Tepa%2C%20Nkawie%2C%20Dunkwa%29%20and%20one%20in%20Benin%20%28Pob%5Cu00e8%29.%20Participants%20were%20included%20if%20they%20were%20aged%205%20years%20or%20older%20and%20had%20typical%20Buruli%20ulcer%20with%20no%20more%20than%20one%20lesion%20%28caterories%20I%20and%20II%29%20no%20larger%20than%2010%20cm%20in%20diameter.%20The%20trial%20was%20open%20label%2C%20and%20neither%20the%20investigators%20who%20took%20measurements%20of%20the%20lesions%20nor%20the%20attending%20doctors%20were%20masked%20to%20treatment%20assignment.%20The%20primary%20clinical%20endpoint%20was%20lesion%20healing%20%28ie%2C%20full%20epithelialisation%20or%20stable%20scar%29%20without%20recurrence%20at%2052%20weeks%20after%20start%20of%20antimicrobial%20therapy.%20The%20primary%20endpoint%20and%20safety%20were%20assessed%20in%20the%20intention-to-treat%20population.%20A%20sample%20size%20of%20332%20participants%20was%20calculated%20to%20detect%20inferiority%20of%20RC8%20by%20a%20margin%20of%2012%25.%20This%20study%20was%20registered%20with%20ClinicalTrials.gov%2C%20NCT01659437.%5CnFindings%5CnBetween%20Jan%201%2C%202013%2C%20and%20Dec%2031%2C%202017%2C%20participants%20were%20recruited%20to%20the%20trial.%20We%20stopped%20recruitment%20after%20310%20participants.%20Median%20age%20of%20participants%20was%2014%20years%20%28IQR%2010%5Cu201329%29%20and%20153%20%2852%25%29%20were%20female.%20297%20patients%20had%20PCR-confirmed%20Buruli%20ulcer%3B%20151%20%2851%25%29%20were%20assigned%20to%20RS8%20treatment%2C%20and%20146%20%2849%25%29%20received%20oral%20RC8%20treatment.%20In%20the%20RS8%20group%2C%20lesions%20healed%20in%20144%20%2895%25%2C%2095%25%20CI%2091%20to%2098%29%20of%20151%20patients%2C%20whereas%20lesions%20healed%20in%20140%20%2896%25%2C%2091%20to%2099%29%20of%20146%20patients%20in%20the%20RC8%20group.%20The%20difference%20in%20proportion%2C%20%5Cu22120%5Cu00b75%25%20%28%5Cu20135%5Cu00b72%20to%204%5Cu00b72%29%2C%20was%20not%20significantly%20greater%20than%20zero%20%28p%3D0%5Cu00b759%29%2C%20showing%20that%20RC8%20treatment%20is%20non-inferior%20to%20RS8%20treatment%20for%20lesion%20healing%20at%2052%20weeks.%20Treatment-related%20adverse%20events%20were%20recorded%20in%2020%20%2813%25%29%20patients%20receiving%20RS8%20and%20in%20nine%20%287%25%29%20patients%20receiving%20RC8.%20Most%20adverse%20events%20were%20grade%201%5Cu20132%2C%20but%20one%20%281%25%29%20patient%20receiving%20RS8%20developed%20serious%20ototoxicity%20and%20ended%20treatment%20after%206%20weeks.%20No%20patients%20needed%20surgical%20resection.%20Four%20patients%20%28two%20in%20each%20study%20group%29%20had%20skin%20grafts.%5CnInterpretation%5CnFully%20oral%20RC8%20regimen%20was%20non-inferior%20to%20RS8%20for%20treatment%20of%20early%2C%20limited%20Buruli%20ulcer%20and%20was%20associated%20with%20fewer%20adverse%20events.%20Therefore%2C%20we%20propose%20that%20fully%20oral%20RC8%20should%20be%20the%20preferred%20therapy%20for%20early%2C%20limited%20lesions%20of%20Buruli%20ulcer.%5CnFunding%5CnWHO%20with%20additional%20support%20from%20MAP%20International%2C%20American%20Leprosy%20Missions%2C%20Fondation%20Raoul%20Follereau%20France%2C%20Buruli%20ulcer%20Groningen%20Foundation%2C%20Sanofi-Pasteur%2C%20and%20BuruliVac.%22%2C%22date%22%3A%222020-04-18%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2FS0140-6736%2820%2930047-7%22%2C%22ISSN%22%3A%220140-6736%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0140673620300477%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T09%3A58%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22F3L9SGJN%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rousset%20et%20al.%22%2C%22parsedDate%22%3A%222020-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERousset%2C%20L.%2C%20Sokal%2C%20A.%2C%20Vignon-Pennamen%2C%20M.-D.%2C%20Pagis%2C%20V.%2C%20Rybojad%2C%20M.%2C%20Lecorche%2C%20E.%2C%20Mougari%2C%20F.%2C%20Bagot%2C%20M.%2C%20Bouaziz%2C%20J.-D.%20and%20Jachiet%2C%20M.%20%282020%29.%20%3Cb%3EAssociation%20d%26%23x2019%3Bune%20l%26%23xE8%3Bpre%20borderline%20tuberculo%26%23xEF%3Bde%20et%20d%26%23x2019%3Bune%20tuberculose%26%23xA0%3B%3A%20un%20cas%20et%20revue%20de%20la%20litt%26%23xE9%3Brature%3C%5C%2Fb%3E.%20Annales%20de%20Dermatologie%20et%20de%20V%26%23xE9%3Bn%26%23xE9%3Br%26%23xE9%3Bologie%20%3Ci%3E147%3C%5C%2Fi%3E%2C%20886%26%23x2013%3B891%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annder.2020.09.571%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.annder.2020.09.571%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20d%5Cu2019une%20l%5Cu00e8pre%20borderline%20tuberculo%5Cu00efde%20et%20d%5Cu2019une%20tuberculose%5Cu00a0%3A%20un%20cas%20et%20revue%20de%20la%20litt%5Cu00e9rature%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Rousset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Sokal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20-D.%22%2C%22lastName%22%3A%22Vignon-Pennamen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Pagis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Rybojad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Lecorche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Bagot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20-D.%22%2C%22lastName%22%3A%22Bouaziz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Jachiet%22%7D%5D%2C%22abstractNote%22%3A%22R%5Cu00e9sum%5Cu00e9%5CnIntroduction%5CnEn%20m%5Cu00e9tropole%2C%20pr%5Cu00e8s%20de%2020%5Cu00a0nouveaux%20cas%20de%20l%5Cu00e8pre%20sont%20diagnostiqu%5Cu00e9s%20chaque%20ann%5Cu00e9e.%20L%5Cu2019incidence%20de%20la%20tuberculose%20en%20France%20est%20de%208%5C%2F100%20000%5Cu00a0habitants%20et%20l%5Cu2019association%20des%202%5Cu00a0mycobact%5Cu00e9ries%20a%20%5Cu00e9t%5Cu00e9%20exceptionnellement%20rapport%5Cu00e9e.%20Nous%20rapportons%20un%20cas%20de%20co-infection%20l%5Cu00e8pre%20Borderline%20Tuberculo%5Cu00efde%20%28BT%29%20et%20tuberculose%20diss%5Cu00e9min%5Cu00e9e%2C%20diagnostiqu%5Cu00e9%20en%20m%5Cu00e9tropole.%5CnObservation%5CnUn%20homme%20pr%5Cu00e9sentait%20des%20plaques%20%5Cu00e9ryth%5Cu00e9mateuses%20infiltr%5Cu00e9es%20hypoesth%5Cu00e9siques%20diffuses.%20La%20biopsie%20montrait%20un%20granulome%20%5Cu00e9pith%5Cu00e9lio%5Cu00efde%20lympho-histiocytaire%20p%5Cu00e9ri-sudoral%20et%20p%5Cu00e9ri-nerveux%2C%20avec%20des%20bacilles%20acido-alcoolo-r%5Cu00e9sistants%20sur%20la%20coloration%20de%20Ziehl.%20La%20PCR%20Mycobacterium%20Leprae%20%5Cu00e9tait%20positive%2C%20confirmant%20le%20diagnostic%20de%20l%5Cu00e8pre%2C%20dans%20une%20forme%20BT.%20Le%20bilan%20d%5Cu2019extension%20r%5Cu00e9v%5Cu00e9lait%20un%20%5Cu00e9panchement%20pleural%20gauche%20%5Cu00e0%20pr%5Cu00e9dominance%20lymphocytaire%2C%20une%20ad%5Cu00e9nopathie%20hilaire%20droite%20%5Cu00e0%20centre%20n%5Cu00e9crotique%20sans%20granulome%20histologique%2C%20une%20recherche%20de%20BK%20n%5Cu00e9gative%2C%20un%20test%20quantiFERON-TB%5Cu2122%20et%20une%20intra-dermo%20r%5Cu00e9action%20%5Cu00e0%20la%20tuberculine%20positifs.%20Le%20tableau%20clinique%20et%20radiologique%20%5Cu00e9tait%20en%20faveur%20d%5Cu2019une%20tuberculose%20diss%5Cu00e9min%5Cu00e9e.%20La%20quadrith%5Cu00e9rapie%20anti-tuberculeuse%20%28rifampicine%2C%20isoniazide%2C%20ethambutol%20et%20pyrazinamide%29%20et%20la%20clofazimine%20permettaient%20une%20r%5Cu00e9gression%20des%20l%5Cu00e9sions%20cutan%5Cu00e9es%20et%20extra-cutan%5Cu00e9es.%5CnDiscussion%5CnCette%20rare%20co-infection%20associe%20une%20l%5Cu00e8pre%20souvent%20l%5Cu00e9promateuse%20%5Cu00e9volutive%20depuis%20plusieurs%20ann%5Cu00e9es%20et%20une%20tuberculose%20souvent%20pulmonaire%20d%5Cu2019apparition%20ult%5Cu00e9rieure.%20L%5Cu2019%20hypoth%5Cu00e8se%20physiopathologique%20est%20celle%20de%20l%5Cu2019immunit%5Cu00e9%20crois%5Cu00e9e%20%28l%5Cu2019immunit%5Cu00e9%20anti-tuberculeuse%20prot%5Cu00e9geant%20contre%20une%20l%5Cu00e8pre%20ult%5Cu00e9rieure%20et%20inversement%29%2C%20%5Cu00e9tay%5Cu00e9e%20par%20la%20corr%5Cu00e9lation%20inverse%20des%20deux%20pr%5Cu00e9valences%20et%20par%20la%20protection%20induite%20par%20la%20vaccination%20antituberculeuse.%20Dans%20la%20plupart%20des%20cas%2C%20le%20traitement%20antituberculeux%20et%20antil%5Cu00e9preux%20permettent%20une%20am%5Cu00e9lioration%20des%20deux%20maladies.%20Un%20cas%20de%20l%5Cu00e8pre%20doit%20faire%20rechercher%20une%20tuberculose%20latente%20afin%20d%5Cu2019%5Cu00e9viter%20une%20r%5Cu00e9activation%2C%20%5Cu00e0%20fortiori%20si%20une%20corticoth%5Cu00e9rapie%20est%20associ%5Cu00e9e.%5CnSummary%5CnIntroduction%5CnIn%20metropolitan%20France%2C%20nearly%2020%5Cu00a0new%20cases%20of%20leprosy%20are%20diagnosed%20each%20year.%20The%20incidence%20of%20tuberculosis%20in%20France%20is%208%5C%2F100%2C000%5Cu00a0inhabitants%20and%20there%20are%20very%20few%20accounts%20of%20association%20of%20these%20two%20mycobacteria.%20Herein%20we%20report%20a%20case%20of%20co-infection%20with%20borderline%20tuberculoid%20%28BT%29%20leprosy%20and%20disseminated%20tuberculosis%20diagnosed%20in%20metropolitan%20France.%5CnPatients%20and%20methods%5CnA%20male%20subject%20presented%20with%20diffuse%20painless%20infiltrated%20erythematous%20plaques.%20The%20biopsy%20revealed%20perisudoral%20and%20perineural%20lymphohistiocytic%20epithelioid%20cell%20granuloma%20as%20well%20as%20acid-alcohol-fast%20bacilli%20on%20Ziehl%20staining.%20PCR%20was%20positive%20for%20Mycobacterium%20leprae%2C%20confirming%20the%20diagnosis%20of%20leprosy%20in%20the%20BT%20form.%20The%20staging%20examination%20revealed%20predominantly%20lymphocytic%20left%20pleural%20effusion%2C%20right-central%20necrotic%20adenopathy%20without%20histological%20granuloma%2C%20negative%20screening%20for%20BK%2C%20a%20positive%20QuantiFERON-TB%5Cu2122%20test%2C%20and%20a%20positive%20intradermal%20tuberculin%20reaction.%20The%20clinical%20and%20radiological%20results%20militated%20in%20favour%20of%20disseminated%20tuberculosis.%20Combined%20therapy%20%28rifampicin%2C%20isoniazid%2C%20ethambutol%20and%20pyrazinamide%29%20together%20with%20clofazimine%20resulted%20in%20regression%20of%20both%20cutaneous%20and%20extra-cutaneous%20lesions.%20This%20rare%20co-infection%20combines%20leprosy%2C%20often%20present%20for%20several%20years%2C%20and%20tuberculosis%20%28usually%20pulmonary%29%20of%20subsequent%20onset.%20The%20pathophysiological%20hypothesis%20is%20that%20of%20cross-immunity%20%28with%20anti-TB%20immunity%20protecting%20against%20subsequent%20leprosy%20and%20vice%20versa%29%2C%20supported%20by%20the%20inverse%20correlation%20of%20the%20two%20levels%20of%20prevalence%20and%20by%20the%20protection%20afforded%20by%20tuberculosis%20vaccination.%20In%20most%20cases%2C%20treatment%20for%20TB%20and%20leprosy%20improves%20both%20diseases.%20Patients%20presenting%20leprosy%20should%20be%20screened%20for%20latent%20tuberculosis%20in%20order%20to%20avoid%20reactivation%2C%20particularly%20in%20cases%20where%20corticosteroid%20treatment%20is%20being%20given.%22%2C%22date%22%3A%222020-12-01%22%2C%22language%22%3A%22fr%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.annder.2020.09.571%22%2C%22ISSN%22%3A%220151-9638%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0151963820310188%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A59%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22ZPF37PZT%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sch%5Cu00f6n%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESch%26%23xF6%3Bn%2C%20T.%2C%20K%26%23xF6%3Bser%2C%20C.%20U.%2C%20Werngren%2C%20J.%2C%20Viveiros%2C%20M.%2C%20Georghiou%2C%20S.%2C%20Kahlmeter%2C%20G.%2C%20Giske%2C%20C.%2C%20Maurer%2C%20F.%2C%20Lina%2C%20G.%2C%20Turnidge%2C%20J.%2C%20Ingen%2C%20J.%20van%2C%20Jankovic%2C%20M.%2C%20Goletti%2C%20D.%2C%20Cirillo%2C%20D.%20M.%2C%20Santin%2C%20M.%20and%20Cambau%2C%20E.%20%282020%29.%20%3Cb%3EWhat%20is%20the%20role%20of%20the%20EUCAST%20reference%20method%20for%20MIC%20testing%20of%20the%20Mycobacterium%20tuberculosis%20complex%3F%3C%5C%2Fb%3E%20Clinical%20Microbiology%20and%20Infection%20%3Ci%3E26%3C%5C%2Fi%3E%2C%201453%26%23x2013%3B1455%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2020.07.037%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2020.07.037%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22What%20is%20the%20role%20of%20the%20EUCAST%20reference%20method%20for%20MIC%20testing%20of%20the%20Mycobacterium%20tuberculosis%20complex%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Sch%5Cu00f6n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudio%20Umberto%22%2C%22lastName%22%3A%22K%5Cu00f6ser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jim%22%2C%22lastName%22%3A%22Werngren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sophia%22%2C%22lastName%22%3A%22Georghiou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunnar%22%2C%22lastName%22%3A%22Kahlmeter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Giske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florian%22%2C%22lastName%22%3A%22Maurer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Lina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Turnidge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakko%20van%22%2C%22lastName%22%3A%22Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mateja%22%2C%22lastName%22%3A%22Jankovic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Delia%22%2C%22lastName%22%3A%22Goletti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Santin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-11-01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2020.07.037%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2820%2930445-6%5C%2Ffulltext%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A53%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22DDZTXD2F%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sch%5Cu00f6n%20et%20al.%22%2C%22parsedDate%22%3A%222020-11-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ESch%26%23xF6%3Bn%2C%20T.%2C%20Werngren%2C%20J.%2C%20Machado%2C%20D.%2C%20Borroni%2C%20E.%2C%20Wijkander%2C%20M.%2C%20Lina%2C%20G.%2C%20Mouton%2C%20J.%2C%20Matuschek%2C%20E.%2C%20Kahlmeter%2C%20G.%2C%20Giske%2C%20C.%2C%20Santin%2C%20M.%2C%20Cirillo%2C%20D.%20M.%2C%20Viveiros%2C%20M.%20and%20Cambau%2C%20E.%20%282020%29.%20%3Cb%3EAntimicrobial%20susceptibility%20testing%20of%20Mycobacterium%20tuberculosis%20complex%20isolates%20%26%23x2013%3B%20the%20EUCAST%20broth%20microdilution%20reference%20method%20for%20MIC%20determination%3C%5C%2Fb%3E.%20Clinical%20Microbiology%20and%20Infection%20%3Ci%3E26%3C%5C%2Fi%3E%2C%201488%26%23x2013%3B1492%2C%20%3Ca%20target%3D%27_blank%27%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2020.07.036%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2020.07.036%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antimicrobial%20susceptibility%20testing%20of%20Mycobacterium%20tuberculosis%20complex%20isolates%20%5Cu2013%20the%20EUCAST%20broth%20microdilution%20reference%20method%20for%20MIC%20determination%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Sch%5Cu00f6n%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jim%22%2C%22lastName%22%3A%22Werngren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuele%22%2C%22lastName%22%3A%22Borroni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Wijkander%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22Lina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Johan%22%2C%22lastName%22%3A%22Mouton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Matuschek%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gunnar%22%2C%22lastName%22%3A%22Kahlmeter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Giske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Santin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20Maria%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Viveiros%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222020-11-01%22%2C%22language%22%3A%22English%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2020.07.036%22%2C%22ISSN%22%3A%221198-743X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2820%2930444-4%5C%2Ffulltext%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-10T10%3A53%3A15Z%22%7D%7D%5D%7D
Avanzi, C., Lécorché, E., Rakotomalala, F. A., Benjak, A., Rapelanoro Rabenja, F., Ramarozatovo, L. S., Cauchoix, B., Rakoto-Andrianarivelo, M., Tió-Coma, M., Leal-Calvo, T., Busso, P., Boy-Röttger, S., Chauffour, A., Rasamoelina, T., Andrianarison, A., Sendrasoa, F., Spencer, J. S., Singh, P., Dashatwar, D. R., Narang, R., Berland, J.-L., Jarlier, V., Salgado, C. G., Moraes, M. O., Geluk, A., Randrianantoandro, A., Cambau, E. and Cole, S. T. (2020). Population Genomics of Mycobacterium leprae Reveals a New Genotype in Madagascar and the Comoros. Frontiers in Microbiology 11, URL: https://www.frontiersin.org/article/10.3389/fmicb.2020.00711 [Accessed March 2022].
BRUUT! (2020). Loulou. 6 March 2020, URL: https://www.youtube.com/watch?v=jPwFWmY271A [Accessed October 2022].
Cambau, E. and Poljak, M. (2020). Sniffing animals as a diagnostic tool in infectious diseases. Clinical Microbiology and Infection 26, 431–435, http://doi.org/10.1016/j.cmi.2019.10.036.
Chauffour, A., Robert, J., Veziris, N., Aubry, A., Pethe, K. and Jarlier, V. (2020). Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses. PLOS Neglected Tropical Diseases 14, e0007857, http://doi.org/10.1371/journal.pntd.0007857.
Cox, V., McKenna, L., Acquah, R., Reuter, A., Wasserman, S., Vambe, D., Ustero, P., Udwadia, Z., Triviño-Duran, L., Tommasi, M., Skrahina, A., Seddon, J. A., Rodolfo, R., Rich, M., Padanilam, X., Oyewusi, L., Ohler, L., Lungu, P., Loveday, M., Khan, U., Khan, P., Hughes, J., Hewison, C., Guglielmetti, L. and Furin, J. (2020). Clinical perspectives on treatment of rifampicin-resistant/multidrug-resistant TB. The International Journal of Tuberculosis and Lung Disease 24, 1134–1144, http://doi.org/10.5588/ijtld.20.0330.
Daley, C. L., Iaccarino, J. M., Lange, C., Cambau, E., Wallace, R. J., Jr, Andrejak, C., Böttger, E. C., Brozek, J., Griffith, D. E., Guglielmetti, L., Huitt, G. A., Knight, S. L., Leitman, P., Marras, T. K., Olivier, K. N., Santin, M., Stout, J. E., Tortoli, E., van Ingen, J., Wagner, D. and Winthrop, K. L. (2020). Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clinical Infectious Diseases 71, e1–e36, http://doi.org/10.1093/cid/ciaa241.
Guglielmetti, L., Low, M. and McKenna, L. (2020). Challenges in TB regimen development: preserving evidentiary standards for regulatory decisions and policymaking. Expert Review of Anti-infective Therapy 18, 701–704, http://doi.org/10.1080/14787210.2020.1756776.
Guglielmetti, L., Huerga, H., Khan, U. and Varaine, F. (2020). WHO 2019 guidelines on drug-resistant tuberculosis treatment: based on evidence or expert opinion? Eur Respir J 55, 1901935, http://doi.org/10.1183/13993003.01935-2019.
Guglielmetti, L., Chiesi, S., Eimer, J., Dominguez, J., Masini, T., Varaine, F., Veziris, N., Ader, F. and Robert, J. (2020). Bedaquiline and delamanid for drug-resistant tuberculosis: a clinician’s perspective. Future Microbiology 15, 779–799, http://doi.org/10.2217/fmb-2019-0309.
Jaffré, J., Aubry, A., Maitre, T., Morel, F., Brossier, F., Robert, J., Sougakoff, W., Veziris, N. and the CNR-MyRMA (Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux) (2020). Rational Choice of Antibiotics and Media for Mycobacterium avium Complex Drug Susceptibility Testing. Frontiers in Microbiology 11, URL: https://www.frontiersin.org/article/10.3389/fmicb.2020.00081 [Accessed March 2022].
Jaspard, M., Butel, N., Helali, N. E., Marigot-Outtandy, D., Guillot, H., Peytavin, G., Veziris, N., Bodaghi, B., Flandre, P., Petitjean, G., Caumes, E. and Pourcher, V. (2020). Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France. Emerg Infec Dis 26, http://doi.org/10.3201/eid2608.191499.
Kort, F., Ray, L. F. L., Chauffour, A., Jarlier, V., Lounis, N., Andries, K., Aubry, A., Guglielmetti, L. and Veziris, N. (2020). Fully weekly antituberculosis regimen: a proof-of-concept study. European Respiratory Journal 56, http://doi.org/10.1183/13993003.02502-2019.
Lan, Zhiyi, Ahmad, Nafees, Baghaei, Parvaneh, Barkane, Linda, Benedetti, Andrea, Brode, Sarah K., Brust, James C. M., Campbell, Jonathon R., Chang, Vicky Wai Lai, Falzon, Dennis, Guglielmetti, Lorenzo, Isaakidis, Petros, Kempker, Russell R., Kipiani, Maia, Kuksa, Liga, Lange, Christoph, Laniado-Laborín, Rafael, Nahid, Payam, Rodrigues, Denise, Singla, Rupak, Udwadia, Zarir F., Menzies, Dick, Ahmad, N., Baghaei, P., Barkane, L., Benedetti, A., Brode, S. K., Brust, J. C. M., Campbell, J. R., Chang, V. W. L., Falzon, D., Guglielmetti, L., Isaakidis, P., Kempker, R. R., Kipiani, M., Kuksa, L., Lan, Z., Lange, C., Laniado-Laborín, R., Nahid, P., Rodrigues, D., Singla, R., Udwadia, Z. F. and Menzies, D. (2020). Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet Respiratory Medicine 8, 383–394, http://doi.org/10.1016/S2213-2600(20)30047-3.
Lecorche, E., Pean de Ponfilly, G., Mougari, F., Benmansour, H., Poisnel, E., Janvier, F. and Cambau, E. (2020). Disseminated Mycobacterium chimaera Following Open-Heart Surgery, the Heater–Cooler Unit Worldwide Outbreak: Case Report and Minireview. Frontiers in Medicine 7, URL: https://www.frontiersin.org/article/10.3389/fmed.2020.00243 [Accessed March 2022].
Lerolle, N., Laanani, M., Galicier, L., Rivière, S., Meynard, J.-L., Azoulay, E., Jeblaoui, A., Lalande, V., Mougari, F., Fardet, L., Coppo, P., Goujard, C., Molina, J.-M. and Lambotte, O. (2020). Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study. The International Journal of Tuberculosis and Lung Disease 24, 124–130, http://doi.org/10.5588/ijtld.19.0856.
Lopes, A., Mougari, F., Chopin, D., Pogliaghi, M., Munier, A., Delcey, V., Simoneau, G., Raskine, L., Evans, J., Mouly, S., Cambau, E., Bergmann, J. and Sellier, P. (2020). Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosis - ScienceDirect. Med Mal Infect 50, 36–42, URL: https://www.sciencedirect.com/science/article/pii/S0399077X18301343?via%3Dihub [Accessed March 2022].
Marsollier, L., Aubry, A., Carbonnelle, E., Canaan, S., Laencina, L., Cambau, E. and Herrmann, J. (2020). Mycobactérioses cutanées dues à Mycobacterium ulcerans, Mycobacterium marinum, Mycobacterium abscessus, Mycobacterium chelonae et autres mycobactéries non tuberculeuses. EM-Consulte, http://doi.org/10.1016/S1166-8598(19)81974-9.
Méchaï, F., Cordel, H., Guglielmetti, L., Aubry, A., Jankovic, M., Viveiros, M., Santin, M., Goletti, D. and Cambau, E. (2020). Management of Tuberculosis: Are the Practices Homogeneous in High-Income Countries? Frontiers in Public Health 8, URL: https://www.frontiersin.org/article/10.3389/fpubh.2020.00443 [Accessed March 2022].
Morel, F., Jaffré, J., Sougakoff, W., Aubry, A. and Véziris, N. (2020). Place de la biologie moléculaire dans le diagnostic de la tuberculose. Revue des Maladies Respiratoires 37, 412–416, http://doi.org/10.1016/j.rmr.2019.09.004.
Ong, C. W. M., Migliori, G. B., Raviglione, M., MacGregor-Skinner, G., Sotgiu, G., Alffenaar, J.-W., Tiberi, S., Adlhoch, C., Alonzi, T., Archuleta, S., Brusin, S., Cambau, E., Capobianchi, M. R., Castilletti, C., Centis, R., Cirillo, D. M., D’Ambrosio, L., Delogu, G., Esposito, S. M. R., Figueroa, J., Friedland, J. S., Ho, B. C. H., Ippolito, G., Jankovic, M., Kim, H. Y., Klintz, S. R., Ködmön, C., Lalle, E., Leo, Y. S., Leung, C.-C., Märtson, A.-G., Melazzini, M. G., Fard, S. N., Penttinen, P., Petrone, L., Petruccioli, E., Pontali, E., Saderi, L., Santin, M., Spanevello, A., Crevel, R. van, Werf, M. J. van der, Visca, D., Viveiros, M., Zellweger, J.-P., Zumla, A. and Goletti, D. (2020). Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). European Respiratory Journal 56, http://doi.org/10.1183/13993003.01727-2020.
Phillips, R. O., Robert, J., Abass, K. M., Thompson, W., Sarfo, F. S., Wilson, T., Sarpong, G., Gateau, T., Chauty, A., Omollo, R., Ochieng Otieno, M., Egondi, T. W., Ampadu, E. O., Agossadou, D., Marion, E., Ganlonon, L., Wansbrough-Jones, M., Grosset, J., Macdonald, J. M., Treadwell, T., Saunderson, P., Paintsil, A., Lehman, L., Frimpong, M., Sarpong, N. F., Saizonou, R., Tiendrebeogo, A., Ohene, S.-A., Stienstra, Y., Asiedu, K. B., van der Werf, T. S., Osei Mireku, S., Abotsi, J., Adu Poku, J. K., Asamoah-Frimpong, R., Osei-Wusu, B., Sarpong, E., Konadu, B., Opoku, E., Forson, M., Ndogyele, M., Ofori, E., Aboagye, F., Berko, T., Amofa, G., Nsiah, A., Mensah-Bonsu, J., Ofori Nyarko, J., Amoako, Y. A., Koranteng Tannor, E., Boakye-Appiah, J., Dzibordzi Loglo, A., Sarpong-Duah, M., Agbavor, B., Ardent, M. F., Yamadjako, A., Adanmado Gersande, N., Adeye, A., Kindjinou, M., Akpolan, Kiki, M., Sodjinou, E., Guegnard, C., Klis, S.-A., Velding, K., Omansen, T., Ofori-Adjei, D., Eyangoh, S., Knell, A. and Faber, W. (2020). Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial. The Lancet 395, 1259–1267, http://doi.org/10.1016/S0140-6736(20)30047-7.
Rousset, L., Sokal, A., Vignon-Pennamen, M.-D., Pagis, V., Rybojad, M., Lecorche, E., Mougari, F., Bagot, M., Bouaziz, J.-D. and Jachiet, M. (2020). Association d’une lèpre borderline tuberculoïde et d’une tuberculose : un cas et revue de la littérature. Annales de Dermatologie et de Vénéréologie 147, 886–891, http://doi.org/10.1016/j.annder.2020.09.571.
Schön, T., Köser, C. U., Werngren, J., Viveiros, M., Georghiou, S., Kahlmeter, G., Giske, C., Maurer, F., Lina, G., Turnidge, J., Ingen, J. van, Jankovic, M., Goletti, D., Cirillo, D. M., Santin, M. and Cambau, E. (2020). What is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex? Clinical Microbiology and Infection 26, 1453–1455, http://doi.org/10.1016/j.cmi.2020.07.037.
Schön, T., Werngren, J., Machado, D., Borroni, E., Wijkander, M., Lina, G., Mouton, J., Matuschek, E., Kahlmeter, G., Giske, C., Santin, M., Cirillo, D. M., Viveiros, M. and Cambau, E. (2020). Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates – the EUCAST broth microdilution reference method for MIC determination. Clinical Microbiology and Infection 26, 1488–1492, http://doi.org/10.1016/j.cmi.2020.07.036.